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 COMPARATIVE STUDY  BETWEEN  FLOURESCENT MICROSCOPY, 
MYCOBACTERIAL  GROWTH  INDICATOR  TUBE  (MGIT) AND GENE 
XPERT FOR THE DETECTION OF MYCOBACTERIUM 
TUBERCULOSIS FROM CLINICAL SUSPECTS OF SMEAR NEGATIVE 
PULMONARY TUBERCULOSIS AND EXTRA PULMONARY  
TUBERCULOSIS PATIENTS. 
 
Back Ground and Objectives: 
Mycobacterium tuberculosis remains one of the most significant causes of death 
from an infectious agent. The rapid diagnosis  of tuberculosis and detection of  anti 
tubercular drug  resistance are essential for early disease management. 
 We determined the performance of the  Fluorescent Microscopy, MGIT, Gene 
Xpert MTB/RIF assay for rapid diagnosis of tuberculosis in smear positive and 
smear-negative pulmonary and  extra pulmonary  specimens obtained from clinical 
and radiological suspects of  tuberculosis patients.  A total 100  patients , among 
them specimens such as sputum and BAL fluid were collected from 49 patients, 
and pleural fluid , ascitic fluid ,Pus, Lymph Node aspirates were collected from 51 
patients. 
Methods: Specimens were digested and decontaminated with standard NaoH-
NALC method for MGIT culture. 
Results: Overall ,Modified Ziehl- Neelsen detected 3,Fluorescent Microscopy 
detected 5, MGIT detected 17 and Gene Xpert detected 26.In smear negative 
pulmonary specimens MGIT detected 8 strains whereas Gene Xpert 10. Among the 
Extra pulmonary specimens ZN detected 3, Fluorescent Microscopy 5, MGIT 
detected  9, and Gene Xpert 16. There was 100 % agreement between Fluorescent 
microscopy, in relation to MGIT culture and Gene Xpert. There was 90% 
agreement between MGIT & Gene X pert with respect to Mycobacterium 
tuberculosis complex identification. 
 
All 10 MTBC strains were sensitive to streptomycin, Isoniazide, Rifampicin and 
Ethambutol, which  is also sensitive for Rifampicin  by Gene Xpert. There was no 
discrepancy in the sensitivity results. Gene Xpert detected 1 MTBC Rifampicin 
Resistant  strain which was not picked up by MGIT.Among the 7 Atypical 
mycobacterias all were resistant to Streptomycin, Isoniazide, and Ethambutol 
,except one strain which was sensitive to Rifampicin by MGIT.  
Conclusion: The results of this study indicated that the implementation of Gene 
Xpert MTB/RIF assay could dramatically improve the rapid diagnosis of 
tuberculosis  particularly in smear negative pulmonary  & extra pulmonary 
specimens such as pus, lymph node aspirates and wound discharges .Gene X pert 
negative specimens can be processed in MGIT  to recover Atypical Mycobacteria . 
Key words: Fluorescent Microscopy, MGIT, Gene Xpert. NALC- N,acetyl-L-
cysteine. 
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INTRODUCTION 
 
“I have no business to live this life if I cannot eradicate this scourge 
from mankind”- Robert Koch. 
 (Delivered a lecture at Berlin University after his discovery of  
tubercle bacilli,  on 24 thAugust 1882) . 
Tuberculosis is an ancient & highly infectious disease that can 
potentially involve any organ or system in the body. Tuberculosis 
remains the major global health problem. It ranks as the second leading 
cause of infectious disease worldwide1. According to WHO report 
2012 there are 8.6 million new cases and 1.3 million TB deaths in 
which, nearly a  million among the HIV negative people and 0.3 
million among the HIV Co-infected people1
.
 
Patients having active TB can infect an average of 10 to 15 
people annually, it kills 5000 people a day, among which 98% of 
deaths are in developing countries  affecting  mostly  young  adults  in  
their   productive age group(35). Higher incidence & Prevalence of 
tuberculosis cases and deaths occur among men, but the burden of 
disease among women& children is also high.In 2012 there 
wasestimated 2.9 million tuberculosis cases & 4 lakh tuberculosis 
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deaths among women, as well as 5 lakh cases & 74 thousand deaths 
among childrens1. 
Among the  cases, around 5 million were smear negative35
.
 
Establishing diagnosis in Smear negative pulmonary specimens such as 
sputum and Bronchio - alveolar lavage fluid constitutes a major 
problem, becauseof  low number of  bacilli.  
In majority Tuberculosis affects the lungs, with features of 
persistent cough with or without expectoration, evening rise of 
temperature, loss of appetite, weight loss, chest pain and hemoptysis50. 
But there are 10 to 15 %&upto 40%22of cases with extra pulmonary 
involvement in developed & low incidence countries7, but the 
prevalence is even more higher in developing countries like India with 
higher incidence of Tuberculosis. Extra pulmonary tuberculosis 
involves lymph nodes, pleura, bone and joints, abdominal, 
genitourinary, neurological, laryngeal, meningeal, ocular and serosal 
membranes7.
 
  The chance of getting extra pulmonary involvement increases 
with immunosuppression & in HIV infected patients. Almost 50% of 
HIV positive individuals is been suffering from extra pulmonary 
Tuberculosis & the disease progresses rapidly7. 
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Atypical clinical presentation of extra pulmonary tuberculosis 
makes the physician difficult in procuring the clinical samples such as 
tissue biopsies, synovial fluid aspirates and bone marrow aspirates. 
Furthermore collection of extra pulmonary specimen often requires 
invasive procedures and it is not so easy to take further samples.                                         
In developing & resource poor countries like India Acid fast 
staining (Ziehl-Neelsen) and culture on conventional Lowenstein –
Jensen medium forms the main modalities in diagnosing 
Mycobacterium tuberculosis5 .Since the no of bacilli is less in smear 
negative & extra pulmonary specimens, only less than 2-5 % of 
specimens shows positivity by Ziehl-Neelsen staining11,25,and this 
makes the microbiologist challenging in getting the yield7. 
WHO has endorsed the implementation of light –emitting 
diode(LED)  auramine  fluorescent microscopy & the GeneXpert assay 
for National Tuberculosis Control Programme inIndia. LED 
fluorescent microscopy is 6% more sensitive compared to traditional 
Ziehl-Neelsenstaining25 . 
Although there are variety of newer molecular methods have 
been introduced in direct detection of Mycobacterium tuberculosis 
complex from clinical specimens rapidly within few hours, culture still 
represents the gold standard  in definitive diagnosis of mycobacterium 
12 
 
tuberculosis25.However culture is not able to provide rapid diagnosis 
for clinical management and also it requiresexpensive & sophisticated 
laboratory facility that may not  be affordable  by most of the resource 
limited setting19. 
 The main disadvantage of this culture (LJ) method is the delay 
in time of detection. As the tubercle bacilli is a slow growing 
organism, it takes more than a month to grow and only very few strains 
grow faster5. The mean time for the detection of culture of 
Mycobacterium tuberculosis on LJ medium is 31±9 days35. 
So it is obligatory to device a rapid & reliable diagnostic 
culturemethod  in  detection of mycobacterium tuberculosis. The 
MGIT system Mycobacterial Growth Indicator Tube, which is a broth 
based liquid culture medium , introduced in 1980 has considerably 
improved the mean time of detection by 18±14 days35. This method is 
very easy to use, noninvasive, and non-radiometric, not labour 
intensive and so can be executed in any laboratory. 
The Xpert MTB/RIF is a fully automated Catridge based  
Nucleic Acid Amplification test with an sensitivity of five genome 
copies of purified DNA  and also it can detect more than 99.5% 
rifampicin resistance mutations ,an indicator of multidrug resistance 
tuberculosis in less than 2 hours.  This requires only minimal biosafety 
infrastructure and training22
.
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Tertiary care hospitals like Medical college hospitals has the 
maximum referral of Extra pulmonary cases for establishing the 
diagnosis. Extra Pulmonary cases of Stanley Medical College from 
2011-2013 statistics  includes 2,379 cases. Because of high case load it 
is necessary to diagnose rapidly and to give the anti tuberculous 
sensitivity as soon as possible to start the treatment early and to 
prevent the complications  Multidrug resistant tuberculosis  pose a 
major public health problem. The magnitude of which is  higher about 
2.2 % 25
.
 
Conventional methods of isolation although specific, take 4-6 
weeks time and have variable sensitivity depending on the type of 
specimen. Susceptibility tests resulttakes   another 3-4 weeks time35.                          
But still the information about the performance of LED fluorescent 
microscopy &Xpert assay for diagnosing Extra pulmonary & smear 
negative  tuberculosis is less compared to pulmonary tuberculosis 
The purpose of this study is to test& compare the efficiency and 
reliability of LED FLUORESCENT MICROSCOPY, liquid culture 
medium(MGIT), & GENE X pert  for the detection of Mycobacterium  
tuberculosisbacteria in smear negative pulmonary specimens and  extra 
pulmonary specimens, and to do anti tuberculous sensitivity pattern by 
Mycobacterial Growth Indicator Tube. 
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AIMS AND OBJECTIVES 
1. Isolation of Mycobacterium tuberculosis from  smears negative 
pulmonary Tuberculosis and Extra pulmonary Tuberculosis 
patients by MGIT – Mycobacterial Growth Indicator Tube, 
Fluorescent Microscopy & Gene Xpert. 
2. To compare the positivity in modified Ziehl- Neelsen staining & 
Fluorescent staining. 
3. Comparison of positivity between MGIT – Mycobacterial 
Growth Indicator Tube and Gene X pert. 
4. To test the antitubercular drug sensitivity by MGIT. 
5. To compare the antitubercular drugsensitivity by MGIT and 
Gene Xpert. 
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REVIEW OF LITERATURE 
History of Tuberculosis 
Tuberculosis is an ancient disease caused by bacillus 
Mycobacteriumtuberculosis. Genus Mycobacterium was originated 
more than 150 million years ago. Gutierrez and her colleagues said 
that, the early progenitor of M. tuberculosis was present in East 
Africa as early as 3 million years ago, and they concluded that it 
must have infected early hominids at that time4. 
               The ancestral home of tubercle bacilli was Eastern parts of 
Africa. In Egypt this disease was evident more than 5000 years ago. 
Typical skeletal abnormalities , such as characteristic pottsspine 
deformities, have been found in Egyptian mummies and were also 
depicted in early Egyptian art4. M. tuberculosis DNA had been 
amplified from tissues of Egyptian mummies. TBspondylitisfirst 
description was written in Sanskrit between 1500 & 700 BC2
.
 
             With the revolution in urbanization & proximity of living the 
epidemic , described as  Great white plague. The incidence has 
increased from mid 1700s following successive pandemic and has 
spread throughout Europewith the peak incidence in 1800s. 
                     Tuberculosis was  noted in the Biblical books of 
Deuteronomy and Leviticus, by  the Hebrew word schachepheth 
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.Tuberculosis is noted in India and China  coined as early as 3300 yrs 
and 2300 years ago one-to-one. As in Egypt, archeological proofof  
tuberculosis is found in America. Bony tuberculosis, such as Potts 
disease is demonstrated in Peruvian mummies. 
In Greece Tuberculosis was baptized as phthisis. Hippocrates clearly 
portrayed and understood the clinical presentation of tuberculosis. 
Phthisis  attacks between the ages of 13 and 35, it was inscribed  in his 
aphorisms, clearly identifying the predilection of young adults. 
Laennec,  clearly described the pathogenesis of tuberculosis and 
amalgamated the concept of the disease, whether pulmonary or 
extrapulmonary.4 
French  surgeon Jean-Antoine Villeminconvincingly  proved the 
infectious nature of tuberculosis, in 1865 after  he inoculated a rabbit 
with a little amount of purulent liquid from a tuberculous cavity 
detached at autopsy from an individual who  died of tuberculosis.  
In his presentation, Koch  presented demonstrations of the tubercle 
bacillus,  his famous postulates, perhaps  called the Koch-Henle 
postulates, which is  set as the standard for the parade of infectious 
etiology.  
 
 
17 
 
RESEARCH JOURNEY OF TUBERCULOSIS 
In 1890 Koch invented Tuberculin , & he injected himself & he 
perceived that he developed an unusual ferocious attack of ague… and 
rise of body temperature & he clinched this might be of use 
diagnostically. 
In 1907 clemensFreiherr von Pirequet noted that positive tuberculin 
testing reflected latent tuberculosis. 
In 1908 Charles Mantoux introduced the use of cannulated needle & 
syringe to inject intradermally. 
IN 1930 Florence Seibert developed Purified protein derivative. 
1859 Herman Brehmer opened his Heilenstat in Silesian Mountain 
village of Gobersdorf where he emphasized a regimen of REST,A 
RICH   DIET,CAREFULLY SUPERVISED EXERCISE. This 
sanatorium is generally considered the first such facility devoted to the 
treatment of tuberculosis. 
Fads and fancies have gathered about so called OPEN AIR 
TREATMENT. 
In 1921 Calmette and his associate CamilleGuerine undertook a 
herculean effort to attenuate M.bovis for use as vaccine. 
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 Acid-fast stain, was first defined by two German doctors: the 
bacteriologist FranzZiehl and the pathologist Friedrich Neelsen  
During World war I there was a high re-emergence. Initially TB 
suspects were screened with X ray alone, and then with tuberculin 
testing followed by BCG vaccination.  In 1974 WHO discouraged both 
radiographic screening & promoted sputum microscopy of 
symptomatic individuals . 
PAS- Para amino salicylic acid  by Gerhard Domagk 
&thiosemicarbamazone  yielded the first therapeutic efficacy  agents . 
Isoniazid was the first oral mycobactericidal drug in 1952 and 
rifamycins in 1957 was invented4
. 
Today Tuberculosis remains endemic in many of the countries like 
India. Several factors added to these drifts ,such as underlying diseases, 
including diabetes, chronic renal failure, chronic obstructive 
pulmonary disease,  cirrhosis of liver, blood leukemias& lymphomas . 
Social factors includes, over crowding, poor nutrition, & migration 
from countries with a high prevalence(2 
EPIDEMIOLOGY 
Tuberculosis remains most important global health problem. It affects 
& kills millions of people each year, and it stands  the second leading 
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cause of death from amongst the infectious diseases world wide, after  
HIV.The Asia and Western Pacific region countries accounts  58% of 
worlds TB cases. INDIA has the leading number of TB cases that is 
26% of the global total. According to WHO global health report 2012 
there were 8.6 million new TB cases & 1.3 million TB deaths in which 
cause 1 million deaths among the non HIV people and 0.3 million 
among  the HIV positives.1 
The burden  among  females and children  is also higher, there are 2.9 
million cases & 410,000 Tb mortality among women in which 250,000 
among HIV negative & 160,000 among HIV positive women, and 
estimated 530,000(6%)  cases & 74,000 deaths among childrens1 
.
Globally TB death  rate dropped by 45% since 1990 & TB incidence 
rate is also  falling in most of the countries
 
 In INDIA incidence of non  HIV  TB patients was 2.4 million , 
prevalence was 3.9 million & HIV positive incident TB cases was 
1,40,000. 
Between the years of  2008& 2013 in INDIA the highest mortality rate 
was 390,000  & the lowest was 170,000 in  the HIV negative 
individuals, & in the HIV positive patients highest TB mortality rate 
was 48,000 & the lowest rate was 37,000. 
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Among the 8.6 million incident TB cases around 1.1 million patients 
are co-infected with HIV1
.
In majority Tuberculosis affects the lungs, 
but there are 10 to 15 %  upto 40%22 of cases with extra pulmonary 
involvement in developed & low incidence countries7. The prevalence 
is even more in developing countries like India with higher incidence 
of Tuberculosis. 
Mycobacterium Tuberculosis  BELONGS TO 
ORDER – Actinomycetales 
GENUS – Mycobacterium 
FAMILY – Mycobacteriaceae 
GENERAL CHARACTERISTICS  
Mycobacterias are non-motile,nonspore forming, weakly Gram 
positive ,aerobic or microaerophilic, straight or slightly curved rod 
(0.2-0.6x1.0 – 10 µm) Sometimes shows coccobacillary or branched 
,or Filamentous form can also be seen ,on slight strife it is fragmented 
into rods or coccoid elements. 
PATHOGENESIS: 
In > 90% of patients infected with M.tuberculosis, the bacteria is in 
latent infection. For active disease to occur  risk of infection is 5% in 
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the first 18 months and 5% for the residual life.3,Roughly 2 billion 
people living worldwide is having latent state. 
Tuberculosis is seen in 2 forms, either from a recent infection(new 
exogenous infection) or from a reactivation of dormant tubercle 
bacilli(old endogenous disease)2
.
The annual risk of getting  pulmonary 
TB following recent primary infection is 300 times more than the 
reactivation.2 In young adults   individuals disease  is mostly due to 
new exogenous infection and in elderly , due to reactivation. 
MANIFESTATION OF TUBERCULOSIS 
Pulmonary TB is commonest form because of inhalational(aerosol)   
spread . Bacteria reaches the blood via the lympho - hematogenous 
route & it coud affect any organ. Because of HIV ,incidence of 
extrapulmonary TB is also increasing . 
PULMONARY TUBERCULOSIS:  
It is divided into primary  and post primary (reactivation)TB 
PRIMARY TB –accounts for 23 to 34%  of adult TB cases2 
Following inhalation of a droplet aerosol containing bacilli ,it come in 
the terminal alveolus & resulting primary parenchymal (Ghon) 
focus,drains via the local lymphatics to the regional lymph 
nodes.Combination of Ghonfocus + lymphangitis + regional lymph 
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node involvement is called Ranke complex,then the disease extends via 
bronchially or hematogenously. 
This  manifestradiologically as parenchymal disease, lymphadenopathy 
,pleural effusion, miliary disease or atelectasis. 
POST PRIMARY TB: 
Results from reactivation of dormant primary infection in > 90 % of 
cases2. 
 This occurs as result of very poor nutrition status, HIV infection, 
cancers, ageing all are associated with high morbidity and mortality. 
Parenchymal disease may demonstrate thecaseous and liquefaction 
necrosis & communicate with  trachea-bronchial tree to form cavities. 
Bilateral upper lobe involvement is most common.Endobronchogenic 
spread is characterized by multiple  micronodules distributed at a 
distant from the cavity site. If left untreated  at the end stage it  leads to 
lobar or complete collapse&opacification. Fibrosis can also occur(2). 
EXTRA PULMONARY TUBERCULOSIS 
Extra pulmonary involvement results from lymphogenous spread or 
hematogenous spread ,frequently a pulmonary focus of infection.Extra 
pulmonary TB constitute about 15 – 20 % of all cases of TB. In HIV 
positive patients it accounts more than > 50 % of cases of TB6,7 . Extra 
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pulmonary tuberculosis involves lymph nodes, pleura, bone and joints, 
abdominal, neurological, laryngeal, meningeal, ocular and serosal 
membranes3.Lymphadienitis , most common form of EPTB followed 
by pleural effusion .Additionally atypical presentation of Extra 
pulmonary TB ,less number of tubercle bacilli present in the  specimen 
makes the diagnosis difficult. Attaining samples is also tough from the 
EPTB cases. 
CLINICAL FEATURES.: 
Pulmonary Tuberculosis – chronic cough, sputum production, loss of 
apetite, weight loss, fever, evening rise of temperature, night sweats 
and Hemoptysis. 
Extrapulmonary TB – patients presents with the symptoms according 
to the organ or system involved3
. 
LAB DIAGNOSIS OF MYCOBACTERIUM. 
Various methods available for diagnosis of TB includes : 
1.Smear microscopy. 
2.Culture on LJ,MGIT,BACTEC. 
3.Serological diagnosis. 
4.Nucleic Acid Amplification methods- PCR,Gene X pert, Line probe 
assay,LAMP. 
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Pulmonary Tuberculosis : 
Before  the start of  treatment precise diagnosis is obligatory. Sputum 
smear microscopy forms the core diagnostic practice in most 
laboratories especially in developing countries like INDIA. The bacilli 
in the sputum can be detected by ZN stain &fluorochromestain,but 
there is a substantial statistical difference in the sensitivity of two 
methods has been reported45
.
 ZN staining has very low sensitivity & 
specificity chiefly in extra pulmonary cases,only 2% 11.In  PTB  after 
concentrating the sputum by petroffs method the sensitivity was 
increased about 44.1% for ZN staining & 71.6% for Auramine O 
staining 29,30,IIgazli et al stated smear positivity of 4.2% in 
EPTB6
.
Smear positivity of  LED microscopy in EPTB was 9.1% and 
the specificity was 95%.25
.
Using a molecular  technique , transmission 
of smear negative patients , to smear positive patients is  22%. As per 
WHO statistics 2004 out of 8.6 million TB cases around 5 million were 
smear negative(35). 
Actually dissimilar results were attained by Jain A et al ZN 32.7%, AO 
41.6%, Githui et al ZN 65%, AO 80%, Besides ZN could detect bacilli 
only when there was 105 bacilli per ml of sputum but AO stain can 
detect 104bacilli per ml of sputum45.  Infection with HIV is known to 
amend the presentation of pulmonary tuberculosis. Fluorochrome 
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staining was  45%  more capable when compared to ZN staining (29%) 
in detecting cases with HIV seropositivity, particularly paucibacillary 
cases27.  
In the early stages of HIV infection, when cell mediated immunity  is 
only partly suppressed , pulmonary tuberculosis presents typically as 
upper lobe infiltrates and cavitation with high bacillary load in the 
sputum, however in the late stages, primary tuberculosis, with diffuse 
interstitial and miliary infiltrates,  no cavitation is appreciated resulting 
in paucibacillary picture of sputum. In the present situation  
withgrowing incidence of HIV a speedy and highly sensitive method 
which can detect paucibacillary cases is the supreme one27
.
sputum 
positivity was less in HIV patients compared to HIV negative patients. 
Smear negative pulmonary tuberculosis is  responsible for 17% of TB 
transmission27. Especially in CSF  the sensitivity of ZN staining is  less 
only 20% 28. 
CULTURE: 
Culturing  Mycobacterium tuberculosis is the gold standard 
investigating  modality. Can be cultured in both solid media and liquid 
media . 
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SOLID MEDIUMS 
Egg based –( Lowenstein-Jensen(LJ),LJ Gruft, LJ with pyruvic acid,LJ 
with iron,petragnani,American Thoracic Society medium,petran-LJ 
with antibiotics.) 
Agar-Based – a)Middlebrook 7H10 &Middlebrook 7H10 selective. 
b)Middlebrook 7H11 &Middlebrook 7H11 selective(Mitchisons) 
c)Middlebrookbiplate(7H10/7H11S agar). 
LIQUID MEDIUMS 
BACTEC 12B medium. 
Middlebrook 7H9 broth. 
Septichek AFB. 
Mycobacterial Growth Indicator Tube. 
For prime recovery of mycobacteria, a minimum of two one liquid 
medium and  anothersolid medium is recommended.  
SOLID CULTURE: 
The advantage of solid media over liquid media is characteristic colony 
morphology,pigmentation, worthy growth from small inocula, & low 
rate of contamination. Atleast  minimum of  two solid culture medias 
should be used & all the specimens should be processed that is 
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digestion ,decontamination and concentration of mycobacteria should 
have been done49
.
Superlative method for concentrating the specimen is 
NaOH-NALC digestion decontamination technique35,36,37.  Moreover 
0.2 ml of processed specimen should be inoculatedand  incubated 
ideally at 370C under 5-10% CO2 atmosphere and with high humidity. 
For the first week cap should be slightly loosened, till the excess water 
to be evaporated, and for the entry of CO2 & should be incubated in a 
slant position. 
  Then the culture tubes should be examined for growth every 
week49
.
Contaminated cultures should be discarded & to be reported as 
CONTAMINATED unable to detect  mycobacteria, & additional 
specimen should be requested. Second specimen must be cultered  
again after improved decontamination. Most of the isolates starts 
growing  between 3 and 6 weeks, few isolates appears after 7 weeks of 
incubation. When growth occurs colony morphology, growth  rate& 
pigmentation shoud be noted. After 8 weeks   slants with no growth 
should be reported  as negative cultures & discarded. 
LJ detected only 53.3% of cultures detected by liquid cultures, 
the mean time of detection of positive cultures were 31±9.4 days35.The 
mean time of detection of  LJ in Smear negative specimens according 
to Badak&Pffffer et al was 31 and 27.2 days respectively.
.
Badak et al 
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who compared between LJ, MGIT & found LJ culture sensitivity from 
smear negative specimen was 58.8% . But the sensitivity is higher if 
the cultures were done from the smear positive specimens. In smear 
positive specimens the sensitivities of LJ medium was higher 
93.5%,85.7% according to Badak&Pfyffer studies respectively(35). 
                         Extra pulmonary TB are often smear negative which 
makes difficulty in diagnosis. The rate of detection of LJ in extra 
pulmonary cases was only 58%11
.
The comtamination rate was 8% in LJ 
,the advantage of sold medium over liquid medium is less 
contamination rate11
. 
MIDDLEBROOKS SOLID MEDIUM 
This media contains defined salts,organiccemicals, agar, 
albumin,biotin&catalase. 
It is transparent allows early detection of growth after 10-12 
days compared to LJ. Only difference between Middlebrook 7H10& 
7H11 is the later contains 0.1% casein hydrolysate which improves the 
rate & amount of mycobacteria resistant to Isoniazid50 
SELECTIVE MIDDLEBROOKS SOLID MEDIUM 
Modification of Middlebrooks medium is addition of antibiotics 
to 7H10 & 7H11 medium which makes it as a selective medium and 
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drops the contamination rate. Mycobacteria grows best at 3-11% 
CO2atmosphere ,if this selective medium is used(50).  
MICRO COLONY DETECTION ON SOLID MEDIA 
 Middle brooks 7H11agar solid medium plates are inoculated , 
incubated and examined microscopically every alternate days . 
In 7 – 10 days micro colonies of mycobacterium can be detected 
, it is less expensive , less time consuming than the LJ culture , 
but it appeared to be less efficient 10,34,50. 
  LIQUID CULTURES: 
MYCOBACTERIAL GROWTH INDICATOR TUBE  ( MICRO 
MGIT) 
Round bottomed glass tube contains Middlebrooks 7H11 broth base - 7 
ml ,a fluorescent compound is implanted in silicone on the base of the 
tube. This fluorescence substance is sensitive to the dissolved oxygen 
in the liquid medium ,& if O2  is there it  quenches the  light. As the 
multiplying  bacteria utilizes all  the oxygen the fluorescence is 
unmasked & it  will  be visible to be  detected by UV light. Growth is 
also  seen as a nonhomogenous turbidity or very  small grain of flakes 
to be seen by naked eyes 50.After adding  supplements such as (OADC 
& PANTA )  with sterile aseptic precautions , in to tube about 0.5 ml 
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of processed specimen using  NaOH – NALC mixture is  added into 
the tube & to be  & incubated  @ 370 C .Tubes to be incubated 
minimum of 6 weeks, & start  reading the tubes from 2 nd day onwards. 
The positive tube should be confirmed for AFB preferebly by ZN 
staining &subculturing on BAP8,8,36,50. 
The recovery rate of MGIT ranged from 65% to 968 especially in 
EPTB specimens. The sensitivity was 91.6% , TTD  was 7-10 days for 
smear positive & 8-44 days for smear negative specimens. The use of 
L-J medium in combinationliquid media increased the positivity to 
93.3%  
MYCOBACTERIAL GROWTH INDICATOR TUBE (MGIT 960) 
 This system is, non-invasive, non- radiometric,easy to use, fully 
automated with high enactment. Advantage over manual MGIT is, it 
itself can incubate &  monitor for every 60 min for the growth by  
fluorescence. There is no considerable difference in the sensitivities 
between the manual MICRO MGIT & automated MGIT10. 
.
Sensitivity of  MGIT960  for smear-negative specimens 75%. 
By combining solid & liquid medium positivity increases. MGIT960  
was found to be positive in 98.%  cases with average time to detect 
growth  around 9.6 days ranges from  (2-39 days) ,and that of LJ 
63.9% sensitive  with average TTD of 28.8 days (6-48 days)and of LJ 
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alone 1.93% . Isolation rates of Mycobacteria in pulmonary and 
extrapulmonary samples were 61.83% and 21.98%  by M960, 44.01%  
and 4.96%  by LJ, respectively35,36. The recovery  time was lesser for   
smear-positive specimens (averages, 11.2 days with the  MGIT 960 
system, 13.6 days, and 22.9 days with Lowenstein - Jensen medium) 
than among smear - negative specimens (18.4, and 32.3days, 
respectively)42. 
BACTEC 460 AFB SYSTEM 
  This instrument embraces a scintillation counter,  which consists 
of  needle aspiration assembly,  which is a  movable track  up to 60 
bottles can be occupied. As each culture bottle in the movable track 
comes beneath the needle  assembly, the needle is depressed through 
the rubber stop and the head gas is removed to get delivered to the 
scintillation counter which , is replaced with fresh 10% CO2, before 
the next bottle is sampled the needle is  sterilized by electrically.The 
BACTEC 12b 20 ml broth bottle contains 4ml of broth culture medium 
consisting of Middlebrook 7H9 broth base;bovine serum 
albumin;casein hydrolysate’catalase and polyoxylene stearate with 
antibiotics and 14C labeled palmitic acid as growth indicator.0.5 ml of 
the concentrated & processed specimen is injected and if mycobacteria 
is present in the specimen 14CO2  is released into the head space which 
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is picked up  by the  detector system and is converted into growth 
index. 
The mean times to detection of mycobacteria in smear negative 
patients were 12, days in   BACTEC460. TheTTD was lesser for 
BACTEC 460 than MGIT tube, and the difference was  not significant 
. The TTD was shorter for MGIT than L-J, and the difference was 
highly  significant35 . 
SEPTI – CHECK AFB SYSTEM. 
 This method allows identification of MTB complex and MOTT 
(atypical mycobacteria) simultaneously contains Middlebrook 
7H9 broth with  CO2 and paddle with agar media inside a plastic 
contains non selective middlebrook 7H11 agar , and on the other 
side with 2 divided agar portions , one half for CA (chocolate 
agar) which allows detection of contamination and the other half 
contains 7H11 agar with NAP - Para - nitro - a -acetylamino - b -
hydroxyl-propiophenone , with which can detect &  
differentiates MTB complex and MOTT. 
 . This method allows identification of mycobacteria from both 
pulmonary and extrapulmonary specimens. A Study conducted 
in USA shown that this method gives better result compared to 
BACTEC 460 TB System10.34.50 
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 Isenberg and coworkers have found & said that this  septi-check 
system was more sensitive than LJ,7H11 and BACTEC broth . 
They concluded that better recovery could be endorsed due to 
biphasic nature of the systems recurrent exposure of agar media 
to  proliferating organisms in broth. 
ESPII BLOOD CULTURE SYSTEM 
This is designed to determine consumption and/or production of 
gas by organisms , helps in getting the yield of mycobacteria from 
blood culture bottle is placed in an incubation module attached to 
sensor , having plastic housing, recessed needle and hydrophic 
membrane, Significant pressure change signated early from the 
consumption of O2. 
Williams Bouyer et al compared ESP culture system II positivity 
rate was 71% for ESP II  . The TTD was 17 days for ESP II and 12 for 
MGIT 10,34,50 
The BACTEC Myco/F LYTIC 
 This culture bottle contains a lytic agent to release the 
mycobacteria that have been phagocytosed  and present inside 
the WBCs’.. 
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    The sensitivity was 81% and the mean time of detection was 
15.3 days34,50 
 MB / BacT , MYCOBACTERIA DETECTION SYSTEM 
          This sytem is designed similar as BacT/Alert blood culture 
system. This bottles contains Middlebrooks 7H9 broth, CO2 ,nitrogen 
and O2undervaccum Mycobacterial Growth supplements and PANTA 
antibiotic mixture reconstituted ,& added. Add 0.5 ml of specimen 
after decontamination , base of bottle contains gas permeable sensor 
changes from green to yellow color when CO2 is produced by 
multiplying bacteria. 
IDENTIFICATION OF MYCOBACTERIAL SPECIES FROM 
THE CULTURE POSITIVE 
1) Biochemical typing 
i. Niacin Accumulation 
ii. Nitrate Reduction 
iii. Tween 80 Hydrolysis 
iv. Catalase Activity 
v. Aryl sulfatase Activity 
vi. Urease Activity 
vii. Pyrazinamidase 
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2) LIPID ANALYSIS : 
o By gas chromatography , mass spectrum and high 
pressure liquid chromatography (HPLC) (10,50) 
o HPLC  
3) PROBE BASED IDENTIFICATION 
o Peptide nucleic acid (PNA) FISH 
o PNA is a novel DNA in which sugar phosphate backbone 
of DNA has been replaced by polyamide. 
4)SHERLOCK MYCOBACTERIAL IDENTIFICATION 
SYSTEM(SMIS) 
                It is based on the mycolic pattern generated by HPLC(HIGH 
PERFORMANCE LIQUID CHROMATOGRAPHY), it uses 
computerized software for mycobacterial detection. 
5)PCR RESTRICTION ENZYME ANALYSIS 
    It exploits 16srRNA gene for & 65 KDahspgene for 
identification. 
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6)DNA CHIPS 
              It involves oligonucleotide arrays or DNA chips, which is 
designed to determine the specific nucleotide sequence diversity 
16srRNA &rpo B gene for identification. 
DETECTION OF MYCOBACTERIA DIRECTLY FROM 
CLINICAL SAMPLES DIRECTLY 
1) GENOTYPIC METHODS 
2) PHENOTYPIC METHODS 
GENOTYPIC METHODS (PCR) 
 Allows amplification of DNA even when there was only few 
copies , it enables rapid visualisation and identification 
The target sequence is IS6110, this deals numerous targets for 
amplification because it is present up to 20 times in the genome. 
In Bangladesh, a study stated the sensitivity and specificity of 
PCR using IS6110 was 94.74% and 100 % against culture 10,34 
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TMA (Transcription mediated amplification) and Nucleic Acid 
Amplification Technique 
Amplified mycobacterial direct test  
 This recognizes MTB complex directly from specimen rapidly 
discriminates from NTM (The sensitivity and specificity against 
cultures on smear positive specimen was 96% and 100%. 
GENEXpert MTB/RIF ASSAY 
Automated molecular NAAT,  detects MTB complex and also 
resistance to rifampin. It is a hemi rested real time PCR assay, 
amplifies  sequence of rpo B gene , then probed with molecular 
beacons for detecting mutations within the Rifampicin  resistance 
determining region and detects within 2 hours. The GeneXpert 
MTB/RIF assay is a , integrated  device which doessample processing 
and real-time PCR analysis in a single hands-free step 
inclinicalspecimens directly20,21,22 In  multi-centre studies, a single 
MTB/RIF test detected 100% of  smear-positive TB patients and about 
3/4 of the smear-negative TB patients& also recognized  rifampicin 
resistance, thus identifying patients who are in need of  second line 
drug treatment(21). This  assay test has intermediate sensitivity which 
means  better than smear microscopy but lesser than broth culture 
prone for false-negative results (20). MTB/RIF test is a major 
38 
 
improvement  in TB diagnosis, but has some restrictions, including the 
limited  diagnostic cartridges, contineous electricity supply, & the need 
for annual servicing and calibration .Among the estimated 500,000 
people who develope MDRTBanually,only 7% are diagnosed(20). 
 The sensitivity and specificity of the test were 82% and 100%, 
respectively for pulmonary specimens. The sensitivities were 100%  
for smear positive and 68%  for smear negative specimens. For 
extrapulmonary samples, the sensitivity was 52% and specificity was 
100%.  The sensitivities for smear positive and smear negative 
extrapulmonary specimens were 100% and 37%, respectively 90% of 
RIF resistant isolates also exhibit resistance to isoniazid (INH)21 
Therefore, the detection of RMP resistance may serve as a  marker for 
MDR TB. The Xpert MTB/RIF assay appropriately identified rifampin 
resistance in 99.1% of patients (21) 
LINE PROBE ASSAY 
Nucleic Acid Amplification techniques which are available today 
allows the prediction of drug resistance in clinical specimens  within 
one working day. One  such molecular technique, GenoType 
Mycobacteria Drug Resistance (MTBDR)  is a commercial assay, uses 
a DNA strip technology and a reverse hybridisation method for a line 
probe assay. The MTBDR assay , introduced in 2004 identifies 
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mutations in the rpoB gene for rifampicin resistance , as well as 
mutations in the katG gene for highlevel Isoniazid  resistance. The 
GenoType MTBDR plus, the second generation assay new  ones also 
detects mutations in the inhA gene that confers resistance to 
lowlevels of INH(52) 
. However, proper laboratory design, standard biosafety practices and 
quality control to avoid crosscontamination are required for the 
MTBDR, which is similar to other nucleic acid amplification assays. 
The BACTEC DST system is cheaper than the MTBDR  it is not easy 
to perform requiring high standards of biosafety. The use of radioactive 
materials, & the need for disposal of radioactive waste, represented the 
major disadvantage of this system. Many previous studies have also 
found that sensitivity (8199%) and specificity (94100%) of 
MTBDR assay for the detection of RIF resistance is high and the most 
common mutation area is codon 531 on the rpoB gene region 
OTHER MODIFICATIONS OF PCR 
 STRAND DISPLACEMENT AMPLIFICATION (SDA) 
 NUCLEIC ACID SEQUENCE BASED AMPLIFIACTION 
(NASBA) 
 BRANCHED DNA (b-DNA) 
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 LIGASE CHAIN REACTION 
 LINE PROBE ASSAY (LIPA) 
Targets in different methods of PCR 
 Target was IS6110 & 16sRNA 
 Spacer oligonucleotide typing ( Spoligotyping) 
 RFLP using IS6110 
 MIRU ( Mycobacterial interspersed repetitive 
unit)PHENOTYPIC METHOD 
   FAST Plaque TB™ 
 This uses mycobacteriophage to detect presence of MTB from 
the sputum specimens, it is a rapid, easy to perform, manual test. 
SEROLOGICAL DIAGNOSIS OF TUBERCULOSIS: 
ANTIGEN DETECTION ASSAYS FROM CLINICAL SAMPLES 
1. Capture ELISA- a quantitative test which detects 
LAM(lipoarabinomannan) from clinical samples such as urine 
,sputum & also extra pulmonary samples. sensitivity& 
specificity is 93% & 95% . 
2. Antigen detection in  fluids  by ELISA, Latex Agglutination & 
Reverse passive haemagglutination test - This can detect free 
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mycobacterial antigen from CSF, Pleural fluid ,at the 
concentration of 3-20ng/ml glycolipids,mycobacterialsonicates. 
The sensitivity & specificity of the these tests ranges from 40-
50% & 80-95%. 
 INDIRECT APPROACH 
 Antibodies to mycobacterial antigens in sera are detected by either 
polyclonal or monoclonal antibodies. False positives can occur. 
1.TB STAT-PAK – Immunochromatographictest,can discriminate 
between dormant or active TB in plasma, serum & whole blood. Its 
sensitivity & specificity is yet to be ascertained in countries like 
INDIA. 
2.ENZYME IMMUNOASSAY FOR DETECTION OF    
ANTIMYCOBACTERIAL SUPEROXIDE DISMUTASE 
ANTIBODY- It is less sensitive in INDIA because the PPV is 77-88% 
3.INSTA TEST TB- It enables antibody detection from blood or 
serum.Commercially available tests are 
a.MycoDotTM(Dot-blot)   using  LAM antigen. 
b.Detect-TB(ELISA)  using  Recombinant protein peptide. 
c.PathozymeMyco (ELISA) using 38kDa Ag & LAM. 
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MISCELLANEOUS DIAGNOSTIC METHODS 
1.TB MPB 64 patch test- This is a specific antigen of 
M.tuberculosiscomplex.Test  becomes positive in 3 to 4 days after 
patch application. specificity is 100% & the sensitivity is 98.1%. 
2.IFN gamma PRODUCING CELL MEASUREMENT- The ESAT 
6,A SPECIFIC Ag ,which induces T cells of  TB patients to secrete 
IFN gamma.The level of IFN gamma increases in treated & untreated 
patients ,helps in monitoring the therapy of TB patients. 
ANTITUBERCULAR SENSITIVITY  
For initial empiric treatment  4-drug regimen: isoniazid, rifampin, 
pyrazinamide, and either ethambutol or streptomycin. The specimen 
should be sent for anti tuberculous sensitivity testing. 
Antimicrobial Susceptibility Testing AST can be  performed by the 
proportion method using LJ medium and  also by automated method by 
BacT Alert 3D system. 
a. LJ Proportion Method : 
 The bacterial suspension  is prepared by picking 2-3loopful of 
colonies into 0.2ml sterile DW in a screw capped  bottle 
(approximately 4mg  weight of the growth in LJ medium). The 
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colonies on the drug free medium  isexpressed as a percentage. 1%  or 
more of growth is considered as resistant for all drugs(58) 
b.BacT Alert 3D Proportion Method : 
 The BacT/Alert MP bottle containing the growth of Mycobacterium 
tuberculosis (≤36 hours, subculture, then the growth was diluted as 1:1 
in sterile DW). This forms the direct growth control of McFarland no.2 
.This is injected  into all drug containing and control bottles. A 100-
fold dilution of the DGC (0.1ml of DGC + 9.9ml of SDW) is prepared 
and 0.5ml is added to another BacT/ Alert MP bottle and this 
coostitutes the 1% growth control (1% GC). These bottles should be  
incubated in the system 12 days at 350c  and monitored to detect the  
growth. An isolate is considered as resistant if the drug containing  
bottles flagged positive at the same time or just  before the control 
tube. An isolate was considered susceptible if the drug containing 
bottle  remained negative during the whole  test period or flagged 
positive after the control tube. If the DGC did not flag positive in 12 
days the test was invalidated and it should  be repeated(58,16,18) 
The average time of detection for  resistance by the LJ proportion 
method ranges from 18-32 days withaverage of 20 days. The drug 
resistant isolates takes  ≥10- 12 days by BACTEC  and 27-32 days by 
LJ method to grow which, was longer than the sensitive isolates.
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Theresistance  detected by LJ which is the ‘gold standard’ for 
comparison, is  in the order of  least effective being isoniazid (44.6%) 
,then ethambutol (17.4%) and rifampcin . Mono drug resistance was 
found in (21.5%) isolates, Isoniazid was the least effective single 
agent58. Resistance to 2 drugs is frequently observed with INH and 
rifampicin (15.7%), 3 drug resistance was among INH, rifampicin 
andethambutol, resistance to >3 drugs was seen in 8.3% cases                                    
MDRTB was 1.7 times morecommon  in pulmonary isolates , 
compared to extra pulmonary using both methods. Among all  the 
second line drugs maximum resistance was seen in Kanamycin (7.4% 
100% agreement was observed for Streptomycin, Amikacin, 
Capreomycin , Rifampicin, Ethionamide, Ciprofloxacin and 
Kanamycin. 91.5% agreement for Isonizaid, 85% for pyrazinamide and 
72.4% for Ethambutol is seen in a study from DELHI(58). 
 As recommended by the IUATLD (2001) sensitivity, specificity,  
(PPV) and  (NPV) of each drugs for the colorimetric BACTEC system 
were determined as compared with LJ method. The sensitivity was 
100% for all the first and second-line drugs. It was lower for 
Ethambutol, 68%,and  87% for  Pyrazinamide and 91.5% for Isoniazid.  
In present study lower sensitivity was observed for pyrazinamide 
(98.3%), isoniazid (95%) and ethambutol (94.7%). 100% sensitivity 
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and specificity was reported for Rifampcin, followed by INH and 
pyrazinamide although streptomycin and ethambutol gave lower 
sensitivity and specificity [12]. Angeby KAK et al. have reported 
100% specificity to all first line drugs and 100% sensitivity for 
ethambutol followed by 96% for isonizaid, 92% for rifampcin and 78% 
for streptomycin .Barreto et al. reported 100% sensitivity and 
specificities  for rifampicin and ofloxacin(58) 
 MYCOBACTERIAL GROWTH  INDICATOR TUBE FOR 
ANTIBIOTIC SENSITIVITY 
One of the promising  & accepted method  in various  settings is the 
fluorimetry based liquid culture detection system, Mycobacterial 
Growth Indicator Tube (MGIT 960) . Reports of “false resistance” to 
INH at a concentration of 0.1 µg/ml recommended by the manufacturer 
haddocumented(16). MGIT tubes supplemented with 0.8 ml of 
supplement (MGIT 960 SIRE supplement; Becton Dickinson) is 
inoculated with 0.1 ml of the drug solution and 0.5 ml of the test strain 
suspension. For preparation of the drug-free growth control tube, the 
organism suspension was diluted 1:100 with sterile saline, and then 0.5 
ml was inoculated into the tube (proportion testing16,17,18. In general, 
the MGIT 960 system tends  to give resistant test results more 
frequently than the Bactec 460 system. 
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                 The results indicated high sensitivity (>91%), specificity 
(>95%) and accuracy (>92%) for detection of INH resistance by MGIT 
960 in comparison to conventional MIC methods. Comparison of 
MGIT 960 with phenotypic methods
.
.Use of MGIT 960 in routine  has 
significantly  reduced the  time for detection of resistance thus giving  
way for early and accurate diagnosis(16.17) 
Multi  Drug Resistant Tuberculosis 
The  multi-drug resistant TB (MDR-TB) is defined as resistance to 
isoniazid and rifampicin in the presence or absence of  resistance to 
other drug. Data from   various studies conducted by Tuberculosis 
Research Centre , have found to have levels ranges from 1% to 3% in 
new cases and about 12% in re-treatment cases. Multi Drug resistant 
tuberculosis is frequently been encountered in India and its presence is 
known virtually from the time  drugs were introduced for the treatment 
3,4
. Six- months curative treatment for TB costs less , but  MDRTB 
treatment costs more. Additionally, MDRTB management requires 
skills and specialist drug supply that currently have  restricted 
availability in the low-income countries where most cases occurs. The 
early diagnosis of drug-resistant TB  iscost-effective , but risk factors 
for TB drug resistance have very  poor predictive value, especially in 
higher prevalence settings 20. Much consideration has focused on the 
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burden of (MDR) TB, i.e., resistance to the first- line drugs  and the 
emergence of extensively drug resistant TB. The rise of resistant TB 
and the increased spread to human population , due to coinfection with 
HIV virus are driving the worldwide TB pandemic and will worsen the 
situation in the years ahead, with devastating effects in poor countries, 
whose economies suffer most from this development17. 
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MATERIALS AND METHODS 
 
STUDY DESIGN: 
Prospective study. 
PLACE OF STUDY: 
           1. Department of Microbiology, Stanley Medical College, Chennai. 
           2. Department of TB and Chest Medicine, Stanley Medical College, 
Chennai 
STUDY POPULATION: 
During this study period, patients with complaints of  cough 
with expectoration & fever for more than 2 weeks , and also patients 
with complaints of suspected extra pulmonary tuberculosis were also 
included in the study.  
            INCLUSION CRITERIA: 
                 Outpatients and inpatients with clinical symptoms suggestive of 
smear negative and  extra pulmonary  tuberculosis such as:  
                -Smear negative Sputum and Bronchi alveolar lavage 
specimens. 
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                - Painless lymphadenopathy with or without abscess 
formation. 
                -pleural aspirates from cases suspected of Tuberculous 
pleural effusion. 
                             -Urine samples from cases suspected of genitourinary 
tuberculosis 
                            -Discharge pus and draining fluid from cases suspected of 
bone and             skeletal tuberculosis. 
                            -CSF in cases suspected of tuberculous meningitis. 
        -other body fluids like ascitic, pericardial with suspected 
extra pulmonary  tuberculosis involvement. 
EXCLUSION CRITERIA: 
Patients on Anti Tuberculosis Treatment. 
STUDY PERIOD: 
January 2014- SEPTEMBER 2014. 
SAMPLE SIZE: 
100 SAMPLES 
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ETHICAL CONSIDERATION:  
Ethical and research clearance was obtained from the Ethical  
committee Stanley Medical College. Permission to conduct the study 
was sought from the respective hospital authorities. Informed consent 
was  obtained from the patients before enrolment in to the study.  
STATISTICAL ANALYSIS:     
Statistical analysis was done with PASW (Predictive Analysis 
SoftWare), Statistics-16 version by statistician. P value obtained by 
Chi  square test.    
 SAMPLE COLLECTION 
1. The patient was  given a sterile wide mouthed , leak proof 
container ( 50 ml Tarsons tubes ) for sputum collection. 
2. Patient was advised to cough and expectorate the sputum, and 
not spit the saliva. 
3. If the patients was able to produce sputum then induced sputum 
was collected . 
EXTRA PULMONARY SPECIMENS 
  All the patients  were clearly explained about the procedure and 
the samples were  collected after following universal precautions . 
51 
 
1.BODY FLUIDS:  By the treating physician, under strict aseptic 
precautions around 10-15    ml of  body fluids such as pleural, Ascitic 
fluid was collected by  aspiration.  
2. PUS SAMPLE  : Under strict aseptic precautions using needle and 
syringe as much material as possible of pus  was aspirated from the 
abscess. eg. Cold abscess and Psoas abscess and cutaneous abscesses. 
3.BRONCHIO ALVEOLAR LAVAGE FLUID. 
Bronchio alveolar lavage fluid was collected in a sterile tarson tubes 
around 10 -15ml from patients with smear negative and suspected 
pulmonary Tuberculosis patients. 
          All the samples were collected in duplicate that is in 2 tarson 
tubes one  forZiehl- Neelsen , Auramine O stain &MGIT Culture  and 
another for Gene Xpert. 
TRANSPORTATION: 
 All the samples were transported immediately to the 
Microbiology laboratory, Stanley Medical College and processed as 
soon as possible to prevent contamination. If there is a delay in 
specimen processing it was stored at 4 -8° C in refrigerators. No 
sample was stored more than 72 hours. 
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SPECIMEN PROCESSING: 
LABORATORY SAFETY: 
Nosocomial transmission  of  M.tuberculosis  from patients or 
specimens is of major concern to the health care workers because of 
the low infective dose of M.tuberculosis  for humans ( 50 % infective 
dose , < 10 bacilli ) , from the known ( or ) suspected cases of 
tuberculosis patients . This should be considered potentially infectious 
and so the specimens should be handled with outmost care and 
appropriate precautions.  Aerosol production and other microbial 
contamination during specimen processing were controlled by using 
appropriate properly functioning Biosafety Cabinets classllb 2 and 
separate air conditioned  room. 
 SMEAR PREPARATION: 
Smear was prepared inside the Biosafety Cabinet  classll b 2, for 
proper disinfection UV light was switched on for half an hour before 
and after handling the specimen inside the cabinet. Clean glass slides 
of 2 numbers were taken and patient details were marked. The 
container was opened and the specimen was taken with a sterile 4 mm 
Nichrome loop and it was spread it over the glass slide for about 1 x 2 
cms. It was allowed to air dry and heat  fixed. One slide was used for 
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acid fast staining by ziehl-Neelsen technique and the another slide was 
used for fluorescent staining (Auramine O staining). 
STAINING METHODS 
Modified Ziehl – Neelsen staining procedure(cold method) 
 Slides were placed on the staining rack with the smear side facing 
upwards 
1. The smear was flooded with strong  Carbol – fuchsin. 
2. Waited for 8 min. 
3. The slide was rinsed with distilled water until all the stains 
were washed away. 
4. Again the slide was flooded with 3% Acid Alcohol solution  
fordecolourisation. 
5. After 3 minutes  slide was thoroughly washedwith distilled 
water. Excess water was drained. 
6. Again the smear was flooded with counter stain Methylene 
blue for 2 minutes 
7. After 2 minutes  the slide was thoroughly  rinsed with 
distilled water and allowed it to air dr 
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MICROSCOPY 
ZN DIRECT SMEAR(AFB POSITIVE) 
 
 
 
 
 MGIT CULTURE SMEAR(AFB POSITIVE) 
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Reporting of Smears: 
 The slides were  examined and interpreted  by the following 
RNTCP grading. 
 
EXAMINATION 
FINDING(AFB 
PER OIL 
IMMERSION 
FIELD 
RESULT GRADING N0 OF 
FIELDS TO 
BE 
EXAMINNED 
> 10 AFB  Positive 3+ 20 
1 – 10 AFB   Positive 2+ 50 
10 – 99 AFB Positive 1+ 100 
1 -9 AFB Positive SCANTY 100 
No AFB  Negative Negative 100 
 
AURAMINE O STAINING: 
a) Heat fixed, dried smears were covered with auramine O 
and allowed to stand for 20 min. 
b) After 20 min smears were washed with distilled water 
and again decolorized with 3% acid alcohol for 3min. 
c) The slide was again washed with distilled water and 
counterstained with potassium permanganate solution  
for 2 min. 
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FLUORESCENT MICROSCOPY 
AURAMINE O  DIRECT SMEAR 
 
 
 
 
AURAMINE O  CULTURE SMEAR(MGIT) 
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d) The smears were allowed to air dry and were examined 
with fluorescent (LED) microscopy under 40 X for 
screening with blue light. 
e) In positive slides smears AFB bacillis were seen as  
bright yellow or green rods under dark background. 
CULTURE METHOD: - 
Tubercle bacilli was cultured in liquid culture medium MGIT ( 
Mycobacterial Growth Indicator Tube). Since liquid culture medium is 
more prone for contamination, Digestion, Decontamination and 
Concentration technique is essential for specimens, especially if it 
known to be contaminated with commensal organisms such as sputum. 
Hence this study includes smear negative sputum samples and extra 
pulmonary samples. Specimens processed accordingly by the 
following described methods given in MGIT manual provided by 
Becton Dickinson. 
For Sputum Samples - NaOH – NALC decontamination, 
digestion procedure was followed and this is the standard 
recommended procedure to be used with MGIT,  which is also 
recommended by CDC. 
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Materials and Methods:  
   Materials Required 
 Disposable 15 ml plastic tubes ( Tarson tubes ) 
 Sterile NaOH – NALC – Sodium Citrate solution 
 Phosphate buffer Ph 6.8 ( 0.067m) 
 Centrifuge with minimum 3000 – 3500 rpm 
 Vortex mixer , shaker 
 Pipettes / Tips. 
Preparation of NaOH – NALC – sodium citrate solution 
a) 4% NaOH – Kills the normal flora. 
b) 9% Citrate – binds the heavy metal ions that might be present 
in the specimen that could inactivate the N – acetyl – L – cysteine 
(NALC). 
c) NALC – Mucolytic agent which liquefies and release AFB 
from the organic matrix of specimen. 
1. 20 g of  NaOH was added to 0.5 l D.W ( 4 % NaOH ). 
2. 14.5 g  Na citrate was added to 0.5 l D.W ( 2.9 % Na Citrate ). 
3.  2 solutions were mixed in a 1 liter bottle and autoclaved for 20 
minutes @ 121°c  at  20 Psi. 
59 
 
             MGIT (PANTA, OADC) 
 
 
                    NAOH NALC , PBS 
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Preparation of Phosphate buffer 0.067 m Phosphate buffer, PH 6.8 
This contains 2 stock solutions: 
a) Disodium Phosphate (Solution A ) – Prepared by dissolving 9.47 d 
of anhydrous Na₂HPO₄ in l lit of D.W. 
b) Mono Potassium Phosphate ( Solution B ) – Prepared by dissolving 
9.07 g of KH₂PO₄. 
After preparing their stock solutions A & B both were mixed together 
and PH was adjusted to 6.8 + 0.2 using PH strips. Finally the solution 
was transferred in to small agent bottles for daily usage and autoclaved 
at 121°c for 20 minutes at 21 Psi and was stored at 2.8°c. 
Sputum Samples: 
a) Around 2 – 5 ml of sputum was collected in 15 ml Tarson tube. 
   b) Equal amount of NaOH – NALC – tri solution citrate solution was 
added to the specimen and the cap was closed tightly.  
  c) Falcon tubes were vortexed  lightly for about 15 – 30 seconds and 
the tubes were inverted so that the whole specimen is exposed to 
NaOH – NALC solution. 
61 
 
d) Waited for 15 – 20 minutes after adding NaOH – NALC solution  
andvortexed lightly every 5 – 10 min. 
e) If the specimen was still mucoid, not liquefied properly even after 
15 min, about (30 – 35 mg/ms) of NALC powder was added directly to 
the specimen tube and mixed well. 
f) At the end of 15 – 20 minutes, the Phosphate buffer (PH 6.8) was 
added up to the top ring on the centrifuge tube. Then the tube was 
mixed well by inverting it several times. 
g) Then centrifuged the tube at a speed of 3000 rpm for 15 – 20 min. 
h) After centrifugation the tubes were allowed to stand for 5 minutes to 
allow the aerosols to settle down. Then the supernatant was carefully 
decant in to the container containing  5 % Lysol (Mycobacterial 
disinfectant). 
i) Finally to the sediment 1 ml of Phosphate buffer (PH 6.8) was added 
to re suspend the sediment with the help of pipette. 
j) The resuspended pellet was used again for inoculation in to MGIT 
(Mycobacterial Growth Indicator Tubes) and for making smears. 
EXTRA PULMONARY SPECIMENS. 
A) 1. STERILE BODY FLUIDS such as pleural fluid, Ascetic 
fluid were collected aseptically. 
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PROCESSING  
 
 
 
                                VORTEXING  
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2. If the specimen was 2 – 3 ml, it was decontaminated as of 
sputum 
3. If the specimen volume was more than 10 ml, then it was 
concentrated by centrifugation at about 3000 rpm for 15 min. 
4. After centrifugation it was decontaminated with equal amount 
of NaOH - NALC solution, after discarding the supernatant. 
5. Phosphate buffer solution (PH 6.8) was added up to the top 
ring and again centrifuged for 15 – 20 min. 
6. Supernatant was discarded in mycobacterial disinfectant and 
the pellet was resuspended in 1 ml of phosphate buffer (PH 6.8) 
7. Around 0.5ml  of processed specimen was inoculated in to 
MGIT tube using pipette. 
       B)  PUS Sample 
             1. Digestion Decontamination procedure varies for Thick and 
Thin PUS  
PUS 
 
                              Thick PUS                        Thin PUS                                                                                    
     Thick pus 
                     0.30 mgs of NALC added directly to the specimen 
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Wait for 15 min 
 
 
                    After liquefying equal amount of NaOH – trisodium 
citrate –       NALC solution was added for decontamination 
                        Then PBS was added until the rim of the tarson tube 
                                      Centrifuged for 15 min @ 3500 rpm 
                                         Supernatant was discarded 
                                     Pellet was resuspended in 1 ml of PBS 
Final resuspended specimen was used for inoculation in to MGIT tubes  
                                                    Thin PUS 
 
   < 10 ml                                                             >10ml 
 
Processed as of sputum with            Centrifuged first for 15 mi @ 3500                                                          
NaOH – NALC solution                 
Supernatant discarded ad 
pellet was again  
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SEDIMENT AFTER PROCESSING  
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resuspended in PBS 
solution 
 
Again processed as of 
sputum with NaOH – 
NALC solution. 
      SWABS 
                                                          SWABS 
Swabs were immediately transferred in to sterile tarson tubes 
Around 2 ml of sterile distilled water was added 
Around 2 ml of NaOH – NALC solution was added 
Centrifuge tubes were tightly closed with the swab and vortexed for 20 
– 30 seconds 
Allowed it to stand for 15 min. 
Swabs were removed with the help of forceps after squeezing the 
liquid out of swab 
PBS solution was added until the top ring 
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Centrifuged @ 3000 rpm for 15 min 
 
Supernatant discarded, sediment was resuspended with 1 ml PBS 
Final resuspended solution was used for smear preparation and 
inoculation in to MGIT tubes. 
   BAL was treated as sputum 
                                                              BAL 
 < 10 ml volume                             > 10 ml volume 
 Decontaminate and digest      Centrifuge for 15 min @ 3000 rpm                                
 like that of sputum                                       
If thick or mucoid    Discard supernatant 
Liquified by adding 30 – 50 mg        Resuspend in sterile distilled water                                                    
of NALC powder                                      
And  decontaminated              Decontaminate like sputum                                                                                 
as of sputum                                     
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PREPARATION AND INOCULATION FOR CULTURE 
1. Reagents 
A) MGIT Medium 
 MGIT 960 tube contains 7.0 ml modified 7H9 broth base ( 
1000 ml of purified water contains) 
- Modified Middlebrooks  7H9  broth base 5.9 gm 
- Casein Peptone 1.25 g 
 Fluorescent sensor embedded in silicone on the bottom of 
the tube. 
 Tube contains 10 % CO2 and it was capped with 
polypropylene screw caps. 
B) MGIT growth Supplement ( enrichment ) 
For manual MGIT (  OADC, 15 ml) is used as growth 
supplement which contains 15 ml of the following 
• Bovine Albumin                         - 50 .0 gm 
• Dextrose                                      - 20.0 gm 
• Catalase                                       - 0.03 gm 
• Oleic acid                                    - 0.1 gm 
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• Polyoxyethyline state (POES)     - 1.1 gm 
C.MGIT PANTA 
Since liquid medium is more prone for contamination, this   
can be reduced by supplementing the medium with mixture 
of antimicrobial PANTA prior to the inoculation of 
specimen. 
Each vial of MGIT PANTA contains a lyophilized mixture of 
the antimicrobials with the concentrations given below 
• Polymyxin B                     – 6000 units 
• Amphotericin B                 – 600 µg 
• Nalidixic acid                    – 2400 µg 
• Trimethoprim                    – 600 µg 
• Azlocillin                           – 600 µg 
2. PROCEDURES 
a) Reconstituting PANTA  
 Reconstituted MGIT PANTA with 15.0ml of MGIT 
growth supplement and mixed until completely dissolved. 
 The enrichment reconstituted PANTA was added to the 
MGIT medium prior to inoculation of specimen.  
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b) Inoculation  into  MGIT medium: 
 MGIT tubes were labelled with specimen name, number 
and date of inoculation. 
  0.8 ml of MGIT growth supplement / PANTA was added 
aseptically in to each tubes. 
 Using a sterile pipette tips, 0.5 ml of well mixed processed 
/ concentrated specimen was aseptically added to the 
MGIT tubes. 
 Separate pipette tips were used for every specimens. 
 The inoculated tubes were recapped tightly and mixed by 
inverting the tubes several times 
 The inoculated tubes and caps were wiped with 5 % Lysol 
and left at room temperature for 30 minutes. 
 All the works were done under Biosafety cabinet class II 
B2. 
              d) Precautions taken care during  Processing: 
 All the additions were done inside in a biosafety cabinet. 
 Tubes were not opened several times. 
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 MGIT tubes were opened as short a period of time as 
possible. 
 Tubes were recapped tightly. 
 Volume greater than 0.5 ml of decontaminated specimen 
may disturb the PH of the medium, and leads to 
contamination and so it was maintained strictly. 
              e) INCUBATION: 
  All inoculated tubes were incubated in 37°c ± 1°c 
incubator 
 The caps were tightly closed and it was not shaked  during 
incubation. This helped  in maintaining the oxygen 
gradient in the medium. 
 The tubes were incubated until it became positive. After 
six weeks of incubation reported as negative. 
QUALITY CONTROL OF AFB SMEAR STAINING AND 
TESTING OF MGIT MEDIUM: 
For positive control M.tuberculosis ,H37Rv(ATCC 27294) was 
obtained from NATIONAL TUBERCULOSIS RESEARCH CENTRE 
,CHETPET. 
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The same was used for positive control for ZN & AO staining ,and for 
negative control gram negative organisms was used. 
One MGIT tube was inoculated with H37Rv for & this was used 
everyday, as positive control while reading the tubes. 
An uninoculated MGIT tube was used as a negative control. 
Few random samples were  also sent to the  Bacteriology department, 
NATIONAL TUBERCULOSIS RESEARCH CENTRE ,CHETPET 
for correlation of results from both the centres. Both the centres 
showed identical results. 
               f) DETECTION OF POSITIVE GROWTH: 
 Starting from the second day onwards, tubes were 
screened for growth by both visually and Micro MGIT 
instrument. 
 Mycobacterial growth appeared granular, with grain of 
flakes appearance and not very turbid, but the 
contaminated bacterial growth appeared very turbid. 
 Growth especially of M tuberculosis Complex settles at 
the bottom of the tube. 
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                                      MGIT POSITIVE 
 
 
 
MGIT NEGATIVE 
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Mycobacterial Growth will utilise all the O2 and so the quenched  
fluorescent substance will be released and it will fluoresce. 
 MICRO MGIT instrument will detect the flourescene and 
will show the positivity. 
 Calibrator control should be checked every day before 
taking up the reading. 
G. WORK UP OF POSITIVE CULTURES: 
 Using a sterile pipette tips under sterile aseptic 
precautions , Smear was prepared from the positive tube , 
heat fixed and left over night and stained with  ZN 
staining. 
 And the smear was examined under oil immersion for the 
presence of AFB. 
 After confirming Acid fast Bacilli in the Positive tube. 
Rapid card test(Immunochromatographic test ) to 
differentiate between Mycobacterium other than tuberculosis 
was done. 
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MGIT POSITIVE 
 
 
TBC ID    NEGATIVE & POSITIVE   
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                  TBCID is a rapid chromatrographic immunoassay 
 This qualitative test detects the  Mycobacterium 
tuberculosis complex (MTbc) antigen from AFB smear – 
positive MGIT tubes. 
Mycobacterium tuberculosis complex includes M. 
tuberculosis complex includes M.tuberculosis, M.bovis, 
M.africanum, M.microti. 
   PRINCIPLE: 
 This detects MPT64, a mycobacterial protein fraction that 
is secreted from MTbc cells during culture. 
 100 µg of sample from the positive tubes was added to 
the well. 
 MPT64 antigen , if present binds to anti MPT64 
antibodies conjugated to visualizing particles on the test 
strip. 
 The antigen – conjugate complex migrates across the test 
strip to the reaction area and is captured by a second 
specific MPT 64 antibody applied to the membrane. 
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 Positives were seen as a colored reactions, produced by 
the labelled colloidal gold particles and was visualized as 
a pink to red link. 
    PROCEDURE 
 All smear positive MGIT tubes were tested in the TBCID 
device within 10 days after positivity. 
 The refrigerated devices were brought to ambient room 
temperature prior to testing. 
 TBCID device was labelled and it was kept on a flat 
surface inside the Biosafety cabinet. 
 The sample was thoroughly mixed by inverting the tube 
several times. 
 100 ml of sample was added using a sterile tips. 
 Result was read after 15 min 
INTERPRETATION OF RESULTS 
A) POSITIVE TEST FOR TBC (MPT 64 antigen present) 
 Pink to red line appears at the test ‘T’ position and the 
control ‘‘c’’ position in the read window. 
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B) NEGATIVE TEST FOR TBC (No MPT 64 antigen detected) 
 No pink to red line was visible at the test ‘‘T’’ position of 
the read window. 
C) INVALID TEST 
 The test was invalid if no pink to red line was visible at 
the control ‘‘C’’ position in the read windows. 
REPORTING OF RESULTS  
1) Positive test was reported as MTb complex. 
Negative test was reported as AFB non –MTbc.                            
   DRUG SUSCEPTIBILITY TESTING 
Before doing Antituberculous sensitivity all the positive tubes were 
subcultured in to BAP  or CAP and SDA to rule out contamination 
with otherbacterias and  fungi. 
PRINCIPLES OF THE TEST 
 TB cultures were subjected to growth in the presence of a known 
concentration of a test drug. A control was also included with no 
addition of drug. If the isolate grows in control tube but not in 
presence of drug was considered susceptible. On the other hand 
if it grows in both tubes it was considered resistant. 
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 Proportion method was used for the susceptibility testing. In this 
method the resistance was established at the 1 % level for most 
of the drugs. This means that if 1 % or more of the total test 
bacterial population is resistant to a drug it is considered as 
resistant for clinical purposes. 
 The bacterial  inoculum in the control was hundred fold less than 
the inoculum in the drug containing medium 
REAGENTS 
       BACTEC MGIT 960 SIRE KIT for critical concentrations 
contains the following drugs in lyophilized form 
a) DRUGS 
 Streptomycin – approximate lyophilized drug per vial – 332µg 
 Isoniazide               – approximate lyophilized drug per vial – 
33.2µg 
 Rifampin       – approximate lyophilized drug per vial – 332µg 
 Ethambutol   – approximate lyophilized drug per vial – 1660µg 
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3) SIRE(Streptomycin, Isoniazide, Rifampicin, Ethambutol)  
SUPPLEMENT 
> Bovine albumin    - 50.0g 
> Dextrose               - 20.0 g 
> Catalase                - 0.03g 
> Oleic acid             - 0.6 g 
STORAGE 
 Upon receipt, the lyophilized drugs were stored at 2-8°c. It was 
reconstituted prior to use once opened and reconstituted, the left over 
drug solutions were aliquoted and it was frozen at - 20°c. Once thawed 
the leftover drugs were discarded which was not restored or refreezed. 
PROCEDURES 
4) a) RECONSTITUTION OF LYOPHILIZED DRUGS 
            Each lyophilized drug vial was reconstituted with 4 ml of 
sterile distilled / deionized water, which was mixed thoroughly and 
make sured that the drug was completely dissolved. 
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b) Addition of a drug to a medium 
   100 µl (0.1ml) of reconstituted drug solution was added 
aseptically, inside the BSC, in to the labelled MGIT tubes. This 
resulted in the following 
Streptomycin - 1.0µg/ml 
Isoniazide         - 0.1 µg/ml 
Rifampin        -1.0µg/ml 
Ethambutol -5.0µg/ml 
AST was done within  fivedays  of  positivity. 
For 1st and 2nd day 
 Tubes was vortexed and allowed to stand for 5 min, then the 
supernatant was used to inoculate into the drug containing tubes, 
& 1 in 100 dilution of the tube was inoculated in to the control 
tube. 
Similarly for Day 3, 4&5 
 1 ml of culture suspension was mixed with 4 ml normal saline to 
form 1 in 5 dilution. 
 From this 100 µl was taken and added in to 10 ml of normal 
saline to make in to 100 dilutions. 
 800 µl of  SIRE supplement was added  on all the 5 MGIT tubes. 
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 500 µl of 1 in 100 dilution of culture suspension was added in 1st 
tube which serves as a growth  control tube. 
 500 µl of 1 in 5 dilution of culture suspension was added in rest 
of the tubes containing Streptomycin, Isoniazide, Rifampicin, 
Etambutol antibiotics respectively. 
 Then the tubes were incubated @ 37°c and  reading was started 
form second day onwars for the the growth. 
RESULTS: - 
 On the day the  control  tube showed positivity, rest of the 
antibiotic containing tubes were read and results interpreted. 
REPORTS: - 
 If there was no growth on the drug containing tube it was 
susceptible. 
 If there was growth present  on the drug containing tube it was 
resistant. 
                                            Gene Xpert 
All the  samples  were  taken  to National Tuberculosis Reseach 
Centre, chetpet for Gene XpertTB/RIF analysis. It is a single step 
procedure Semi nested multiplex real time PCR.  
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1. Clinical specimens which were collected in Tarsonstubes  
were  treated with a sodium hydroxide and isopropanol-
containing sample reagent/lysis buffer (SR), in the ratio of 
4:1  and kept  at room temperature for 15 min and were also 
vortexed twice, this step  reduces  the viability of M. 
tuberculosis in specimen. After which around 2 ml was added 
to the sterile cartridges manually.Each specimen loaded 
cartridge has a barcode,  which when scanned will indicate 
the position of its placement.  
2.Subsequent processing is fully automated. 
3.This assay employs single-use 11 chambered  plastic cartridges that 
are preloaded with liquid buffers and lyophilized dried beads with  
necessary reagents for sample processing, DNA extraction and 
seminested real time-PCR. 
4..The cartridge includes a syringe drive, a rotary drive and a filter at 
the base  upon which M. tuberculosis bacilli gets  deposited after  
liberated from the  specimen.  
5.  The  platform has  a sonic horn that inserts into the cartridge base to 
cause ultrasonic lysis of the bacilli which  releases  the  DNA , is  then 
amplifies  192 bp segment of  the rpoB gene by  a hemi-nested real 
time-PCR reaction . 
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CATRIDGE 
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6. QUALITY CONTROLS  
  The also has  lyophilized Bacillus globigii spores  as an internal 
sample processing and PCR control. The B. globigii PCR assay is 
multiplexed with the M. tuberculosis assay. 
Mycobacterium tuberculosis is detected by the five overlapping 
molecular probes (probes a,b,c,d.e) that  are complementary to 
the  81 bprpoB core region . M. tuberculosis is detected ,at least 
two of the five probes give positive signals within the  cycle 
threshold (CT) of less than or equal to 38 cycles.  
RESULTS 
The B. globigii internal control is positive when the single B. 
globigii -specific probe produces graph  at CT of ≤38 cycles. The 
standard user interface indicates the presence or absence of M. 
tuberculosis and the presence or absence of rifampicin resistance. 
INVALID RESULTS 
 No graph  for both  M. tuberculosis and for the B. globigii 
internal control are reported as invalid assays.  
RIFAMPICIN RESISTANCE RESULTS 
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SCANNING THE BARCODE 
 
 
 
MTB GRAPHS – GENE XPERT 
 
SEDIMENT AFTER PROCESSING  
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Rifampicin resistance is detected by the difference between the first 
(early Cycle Threshold) and last (late CT) of M. tuberculosis -specific 
beacon . The system was  configured such that resistance was reported 
when ∆CT was >3.5 cycles and sensitive if ≤3.5 cycles. Since the 
assay terminates after 38 cycles, the assay was deemed indeterminate 
for rifampicin resistance if the first probe CT is >34.5 cycles and the 
last probe has a CT of >38 cycles . 
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OBSERVATION & RESULTS 
 
Totally Hundred patients suspected of having tuberculosis 
infection were included in this study from the department of TB and 
Chest Medicine for the detection of mycobacterium tuberculosis in 
Smear negative pulmonary specimens  and Extra pulmonary specimens 
.Among them sputum(40), Bronchio-alveolar lavage fluid(9) , pleural 
fluid(31) ,ascitic fluid(5), pus/empyema(7), Psoas abscesses(2), Breast 
abscess with sinus tract discharge(1), lymph node aspirates(3) were 
collected and processed to detect the presence of mycobacterium 
tuberculosis by LED fluorescent Microscopy, MGIT (Mycobacterial 
Growth Indicator Tube) and Gene Xpertat the Department of 
Microbiology periodically between January 2014 to September 2014. 
The results were analyzed using SPSS Software version 16.  
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Table-1 : AGE DISTRIBUTION: 
Age in years Pulmonary 
symptoms 
Extra 
pulmonary 
Total 
≤ 20  4 5 9 
21 - 40  9 22 31 
41 - 60  21 18 39 
> 60  15 6 21 
Total 49 51 100 
p valve 9.614 
Mean Age  56.3 
df value 3 
Asymp.Sig 0.022 
 
 The commonest age group was 41 to 60 years.   
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Table 2 : GENDER DISTRIBUTION IN PULMONARY AND 
EXTRA PULMONARY SPECIMENS. 
 
 Pulmonary Extra 
pulmonary 
Total 
 
Male 36 38 74 
Female 13 13 26 
Total 49 51 100 
P value 0.014 
Df 1 
Fishers 
Exact Test 
1.000 
 
Among tuberculosis suspected patients 74% were males, and 26% 
were females, this is statistically significant, and they were equally 
distributed in both pulmonary and extra pulmonary category. 
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 Table 3 : SOCIO ECONOMIC STATUS ACCORDING TO 
KUPPUSAMY CRITERIA
 
Patients With 
Symptoms Of 
Lower 
Upper lower 
Lower middle 
Upper middle 
Upper 
P value 
Df value 
 
Among them, most of the 
followed by upper middle class. 
93 
. 
Pulmonary 
(49) 
Extra 
pulmonary 
51 
- - 
1 - 
25 32 
22 18 
1 - 
3.465 
3 
patients belongs to lower middle class 
 
Total  
- 
1 
57 
40 
1 
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Table 4 : PRESENTING COMPLAINTS. 
 
Complaints 
 
Pulmonary 
TB 
Extra 
Pulmonary 
TB 
Total 
 
Male Fem
ale 
Male 
 
Fem
ale 
 
H/O Constitutional symptom(62) 17 5 33 7 62 
Cough with expectoration(22) 13 4 3 2 22 
Hemoptysis(25) 22 3 - - 25 
Breathlessness, Chest Pain(40) - - 36 4 40 
Abdominal Distention/ Ascitis(5) - - 3 2 5 
Neck Swelling(5) - - 5 - 5 
Breast Abscess with chest wall 
Discharge(1) 
- - - 1 1 
 
The commonest complaint was constitutional symptoms 62%, 
followed by breathlessness in extra pulmonary& Hemoptysis in  
 pulmonary TB suspected patients.
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Table 5 : ASSOCIATED DISEASES. 
Patients With Symptoms Of Pulmonary Extra 
Pulmonary 
Total 
Diabetes Mellitus(7) 4 3 7 
Hypertension(2) 2 - 2 
Carcinomas 
 
Pancreatic(2) - 2 2 
Bronchogenic(1) - 1 1 
Laryngeal(1) - 1 1 
COPD(2) 2 - 2 
Asthma/Pneumonia(2) 2 - 2 
Carcinoid Lung(1) 1 - 1 
DM/HT(3) 2 1 2 
 
Most common associated diseases among the tuberculosis 
suspected patients was Diabetes Mellitus(7%) followed by 
carcinomas(4%) 
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 Table 6 : PAST  H/O TB AND TREATMENT H/O
 
Past H/O TB 
Pulmonary(9) 
Extra Pulmonary(3)
Total-12 
 
Among the 12 patients who had past H/o tuberculosis 
completed  treatment and 2 patients defaulted. 
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ATT  Taken Treatment 
Defaulter
7 2 
 3 - 
10 2 
 
10 patients 
 
 Table 7 :  INVESTIGATIONS PROFILE FOR SYMPTOMATIC 
SMEAR NEGATIVE PULMONARY CASES.
 
Patients with 
Lymphocytosis
Sputum 
(40) 
BAL Fluid 
(9) 
 
Out of 49 tuberculosis
peripheral lymphocytosis and one
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Peripheral Smear 
 
HIV Status
 
(>70%) 
Normal 
Count 
Positive Negative
21(42%) 17(38%) 1 
5 4 - 
 suspected patients 21(42%) 
(2%) patient was HIV positive
 
 
39 
9 
patients had 
. 
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Table 8 :  INVESTIGATIONPROFILE FOR SYMPTOMATIC  
EXTRA PULMONARY CASES 
 
Patients  with 
 
Lymphocyte 
Count in                        
Fluid (>70) 
ADA 
(>50 U/L) 
HIV Status FNAC 
wnl Inc wnl inc + ve  -ve  +ve -ve 
Pleural Fluid 
(31) 
13 18 17 16 
 
1 30 - - 
AsciticFluid 
(5) 
3 2 4 1 - 5 - - 
Pus 
(9) 
Empyema(7) - - - - 1 8 - - 
Psoas 
Abscesses(2) 
 
Sinus tract / wound 
discharges(3)  
- - - - - - - - 
Lymph Node 
Aspirate (3) 
- - - - - 3 3 - 
 
wnl – Within Normal Limits, inc – Increased, +ve – Positive, 
 -ve – Negative. 
18 patients  had increased lymphocytosis and 16 had increased ADA 
count in pleural fluid. All 3 of the  lymph node aspirates were positive 
for tuberculosis by Fine Needle Aspiration Cytology. 
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 Table 9 : DIRECT MICROSCOPY BY 
ZIEHLNEELSEN STAINING &AURA
EXTRA PULMONARY SPECIMENS.
 
Extra pulmonary 
specimens 
n=51 
Pleural Fluid( 31)
Ascitic Fluid( 5 )
Pus(9) 
 
 
Empyema
 Psoas 
Abscesses(2)
Wound 
Discharges(3
) 
Sinus tract 
Discharge(2)
Ulcer(1)
Lymph node Aspirate(3)
Total 
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MINE O STAINING IN 
 
Before concentration 
n= 51 
After Concentration
Ziehl 
Neelsen 
Stain 
Auramine 
O Stain 
Z
Neelsen
Stain
 - - 
 - - 
(7) 2 
(3.9%) 
2 
(3.9%) (5.9%)
 
 
 
- - 
 
 - - 
2 2 
MODIFIED 
 
n=51 
iehl 
 
 
Aura 
mine 
O Stain 
- - 
- - 
3 
 
3 
(5.9%) 
- 1(1.8%) 
- 1 
(1.8%) 
3 5(9.8%) 
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AuramineO staining after concentration detected 5(9.8%) samples. 
Ziehl-Neelsen staining detected 2(3.9%) samples before concentration 
and detected 3(5.9%) samples after concentration. 
There is no difference in the detection of  modifiedZiehl-
Neelsen&Auramine  O staining methods before concentration. 
Sensitivity of processed Auramine  O staining  after concentration for 
Extra pulmonary specimens is 30% & specificity is 97%.Overall PPV 
is 87.3% and for Extra pulmonary specimens it was 80% in this study. 
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Table 10 : CULTURE POSITIVITY BY MGIT  IN SMEAR 
NEGATIVE  PULMONARY & EXTRA PULMONARY 
SPECIMENS. 
 
Category 
n=100 
Specimen MGIT +ve MGI
T 
-VE 
CONTA
MINATE
D 
CULTUR
ES 
MTB
C 
MOTT 
Pulmonar
y 
(49) 
Sputum 
(40) 
3 3 30 4 
BAL Fluid 
(9) 
- 2 7 - 
PUL-
Total 
49 3 5 37 4 
 
 
 
 
 
Extra 
pulmonar
y 
(51) 
Pleural 
Fluid(31) 
1 1 27 2 
Ascitic 
Fluid (5) 
- - 5 - 
 
Pus(9) 
Empyema(
7) 
3 1 2 2 
Psoas 
Abscess(2 
Sinus Tract/Wound 
ischarge (3) 
1 - 2 1 
Lymph Node 
Aspirates(3) 
2 - 1 - 
EXT 
PUL-
Total 
51 7 2 37 5 
TOTAL 100 10 7 74 9 
 
MTBC- Mycobacterium tuberculosis complex. 
MOTT-Mycobacterium Other Than Tuberculosis Complex,  
Pul-Total- pulmonary Total, EXT- Total- Extra pulmonary Total 
 
 Recovery rate for extra pulmonary specimens was 9/51(18.5%). 
Among Extra pulmonary specimens, the positivity was higher for pus 
specimens out of 9/51(18%) specimens it detected 5/9(55.6%).
Out of 100%, 9%  of cultures were 
organisms & 74% of them were negative.
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contaminated with gram positive 
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Table 11 : ANTIMYCOBACTERIAL SENSITIVITY TESTING 
RESULTS BY MGIT 
 Streptomyc
in 
Isoniazid Rifampicin Ethambutol 
Sen 
 
Res 
 
Sen Res Sen Res Sen Res 
 
Sputum(6) 
 
MTBC (3) 3 - 3 - 3 - 3 - 
MOTT (3) - 3 - 3 - 3 - 3 
BAL 
fluid(2) 
MOTT (2) - 2 - 2 - 2 - 2 
Pleural 
Fluid(2) 
MTBC (1) 1 - 1 - 1 - 1 - 
MOTT (1) - 1 - 1 1 - - 1 
Pus(5) 
 
MTBC (4) 4 - 4 - 4 - 4 - 
MOTT (1) - 1 - 1 - 1 - 1 
Sinus Tract 
Discharge 
(1) 
MTBC (1) 1 - 1 - 1 - 1 - 
Lymph 
node 
aspirate(1) 
MTBC (1) 1 - 1 - 1 - 1 - 
 
MTBC- MYCOBACTERIUM TUBERCULOSIS COMPLEX, 
MOTT-MYCOBACTERIUM OTHER THAN TUBERCULOSIS. 
Sen-Sensitive,Res-Resistant 
All  10/17 of MTBC strains  were sensitive to all four drugs 
Streptomycin, Isoniazide, Rifampicin, Ethambutol. 
Among the 7/17 of MOTT all where  resistant to three drugs 
streptomycin , Isoniazide, Ethambutol, except one strain which was 
sensitive to rifampicin. 
  
  
ATYPICAL MYCOBACTERIA RESISTANT TO 
ALL(MGIT) 
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(MGIT) Table 12 : SPECIMEN WISE GENE X PERT RESULTS  
AND RIFAMPICIN SENSITIVITY. 
Category 
 
n =100 
Specimen Positive 
 
Negative Invalid/ 
Error 
Rifampicin 
S 
 
R 
 
Pulmonary 
(49) 
Sputum(40) 10 28 2 9 1 
BAL(9) - 9 - - - 
Pul-Total 49 10 37 2 9 1 
 
 
 
 
Extra 
pulmonary 
Pleural Fluid (31) 4 27 - 4 - 
Ascitic Fluid (5) - 5 - - - 
Pus(9) Empye
ma(7) 
8 1 - 
  
8 - 
Psoas 
abscess(
2) 
Wound 
Discharges (3) 
1 2 - 1 - 
Lymph Node 
Aspirate(3) 
3 - - 3 - 
Ext Pul -
Total 
51 16 35 - 16 - 
Total 100 26 72 2 25 1 
 
S- sensitive, R-Resistant, Pul- pulmonary,Ext- Extra pulmonary. 
In total GENE X pert /RIF detected 26%, in Smear Negative 
Pulmonary  samples it detected  10/49(20%). It detected  16/51(31%) 
in extra pulmonary specimens. 
Among the  9 pus samples it detected 8/9(89%).In lymph node  
aspirates out of 3  specimens it detected all the 3/3(100%). 
 Out of 26 % of positivity, one strain wasRifampicin resistance, rest all 
were sensitive. 
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13. TIME OF DETECTION OF POSITIVE SAMPLES BY MGIT. 
Category MGIT In Days 
Time Of Detection(Days) <5 6 -
10 
11 -
15 
16 -
20 
21-
25 
26 -
42 
Pulmonary Sputum (6) 
 
1 3 1  1  
Bronchio 
Alveolar Fluid(2) 
1 1     
Extra 
Pulmonary 
Pleural Fluid(2) 1  1    
Ascitic Fluid       
Pus(5) 1 2 1  1  
Swab(1)  1     
Lymph Node 
Aspirate (1) 
 1     
 Total 4 8 3 - 2 - 
 
The mean time of detection of MGIT was 9.6 days. 
The mean time of detection for MOTT is just 5.8 days.  
The mean time of detection for pulmonary specimens is 9.3 days. 
The mean time of detection for Extra  pulmonary specimens is 9.8 
days. 
The mean time of detection of MOTT is very less 5.8 days compared 
to Mycobacterium tuberculosis complex. Gene X pert detected all 
 samples in less than 2 hours.
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 Table 14 :  POSITIVITY BY FLUORESCENT MICROSCOPY, 
MGIT and Gene Xpert
Detection method
Fluorescent Microscopy
MGIT 
Gene X pert
 
 Gene X pert detected maximum by 26%, secondly MGIT 17% and last 
Fluorescent Staining 5%
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 Number positive 
 5 
17 
 26 
. 
% 
5% 
17% 
26% 
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Table 15 : COMPARISON OF POSITIVITY BY MGIT 
CULTURE & GENE X PERT, IN RELATION TO 
FLUORESCENT MICROSCOPY. 
Category Specimen FLUORES
CENT 
/MICROSC
OPY 
MGIT POSITIVE 
MTBC MOTT Gene 
Xpert 
Positive 
Smear 
Negative 
Pulmonary 
Sputum 
(40) 
- 3 3 10 
BAL 
         (9) 
- - 2 - 
PulTotal 49 - 3 5 10 
 
 
 
 
 
 
Extra 
Pulmonary 
Pleural Fluid Negative 
(31) 
1 1 4 
Ascitic Fluid Negative 
(5) 
- - - 
Pu
s 
Psoas 
abscesses 
Positive 
(3) 
3 - 3 
Empyem
a 
Negative 
(6) 
1 1 5 
Wound 
Discharges 
Positive 
(1) 
1 - 1 
Negative 
(2) 
- - - 
Lymph Node 
Aspirate 
Positive(1) 1 - 1 
Negative(2) - - 2 
Ext Pul 
Total 
 Positive-5 7 2 16 
Total  5 10 7 26 
Pul-Pulmonary, Ext Pul- Extra pulmonary. 
Sensitivity ,specificity, PPV, NPV of Fluorescent Microscopy is 
29.4%,100%,87.3%,100%. 
Overall including  MTBC& MOTT the sensitivity & specificity of 
Gene X pert is 60% and 78%. 
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Table 16 :RECOVERY RATE  OF MYCOBACTERIUM FROM 
CLINICAL SAMPLES  BY MGIT & GENE X PERT IN 
RELATION TO SMEARS. 
 
S.No MGIT  Gene X 
Pert(MTB 
Complex) MTB 
Complex 
MOTT MGIT 
TOTAL 
Smear Neg 
Pulmonary 
(49) 
3(6.1%) 5(10.2%) 8(16.3%) 10 
Smear Pos Extra 
Pulmonary 
(5) 
5(100%) - 5(100%) 5 
Smear Neg Extra 
Pulmonary  
(46) 
2(4.3%) 2(4.2%) 4(8.6%) 11 
TOTAL 10 7 17 26 
 
In 49 smear negative pulmonary specimens  MGIT detected  8/49( 
16.3%).Out of which 5 (10.2%) were MTBC & 3(6.1%) were 
MOTT.Gene X pert detected  10/49 (20%).  
Out of 5 smear positive Extra pulmonary specimens  MGIT& Gene X 
pert detected 5/5(100%) all belongs to MTBC .There was 100 % 
agreement  
In smear negative Extrapulmonary specimens 46/51MGIT detected 
4/46(8.7%) among them 2(4.3%) MTBC ,&2(4.3%) were MOTT , 
Gene X pert detected 11/46(24%) and it also detected extra 7/46 
 (15.2%). 
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 Table 17 :POSITIVITY OF GENE X PERT & FLUORESCENT 
MICROSCOPY IN RELATION TO MTB COMPLEX MGIT 
CULTURE POSITIVITY.
 
Specimens 
n=10 
Smear negative 
pulmonary(3) 
Smear positive 
Extra pulmonary 
TB(5) 
Smear negative 
Extra pulmonary 
TB(2) 
TOTAL(10) 
 
Out of 10 of MGIT positive MTB complex cultures, Gene X pert 
detected 9 (90%) ,so there is 90% agreement.
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MGIT, MTb 
Complex 
Culture 
Positive 
Fluorescent 
Microscopy 
Positive 
3 - 
5 5 
2 - 
10 5 
 
Gene X Pert 
Positive 
2 
5 
2 
9 
 
  
 
 
MGIT POSITIVE ,GENE X PERT NEGATIVE
GENE X PERT POSITIVE, MGIT NEGATIVE
MGIT AND GENE Xpert
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-1  
-17 
POSITIVE- 9 
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Table 18 : COMPARISON OF MTB COMPLEX SENSITIVITY 
RESULTS BY MGIT & GENE X PERT. 
 
 MGIT GENE X PERT 
SEN RES SEN RES 
STREPTOMYCIN 9 - NA - 
ISONIAZIDE 9 - NA - 
RIFAMPICIN 9 - 9 - 
ETHAMBUTOL 9 - NA - 
 
100 % AGREEMENT 
There is no discrepancy in antibiotic susceptibility results by both 
MGIT & Gene X pert out of 9 samples detected by both methods. 
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DISSCUSSION 
According to WHO report 2012 there are 8.6 million new cases 
and 1.3 million TB deaths per year1.In India out of one billion total 
population , around 2 million develop active TB and 50% of them die 
each year.  
The present  study was conducted  to test & compare the 
efficiency and reliability of LED Fluorescent Microscopy, liquid 
culture medium(MGIT), & GENE X pert  for the detection of 
Mycobacteriumtuberculosisin smear negative pulmonary specimens 
and  extra pulmonary specimens, and to do anti tuberculous sensitivity 
pattern by Mycobacterial Growth Indicator Tube. 
Totally 100 patients suspected of having tuberculosis infection 
were included in this study ,among them sputum &Bronchio- alveolar 
lavage fluid were collected from 49 patients, pleural fluid(31) ,ascitic 
fluid(5), pus/empyma(7), Psoas abscesses(2), Breast abscess with sinus 
tract discharges/wound discharges(3), lymph node aspirates(3) were 
collected from 51 patients and processed. 
 
120 
 
 
Table-1 : Age Distribution: 
.Among the  tuberculosis suspected patients the commonest age 
group was 41 to 60 years, and the mean age was 56.3years in this study 
which correlates with the study conducted by Salome64Phelamei et al 
 in which the age group affected was 15 to 54 yrs. 
Table 2 : Gender distribution in pulmonary and extra pulmonary 
specimens  
Among the tuberculosis suspected patients 74% were men and 
26% were women, this is highly significant, and they were equally 
distributed in both pulmonary and extra pulmonary category.This 
correlates with  study of Mohamed35 et al where 78% of men and 22% 
of women affected35.According to Olivier65 et al because of unique  sex 
specific genetic architecture in men, they have a complex of genes 
HLA class I ,NRAMP 1 and TLR which makes them susceptible to 
Tuberculosis.But  in females oestradiol enhances macrophage 
activation, which in turn increases TNF α ,which provides protection. 
Table 3 : SOCIO ECONOMIC STATUS ACCORDING TO 
KUPPUSAMY CRITERIA. 
In this study most of the patients belongs to lower middle 
class(57). 
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  This correlates withDeeraj kumar63 et al, in which patients with lower 
socio- economic status has a higher risk of tuberculosis.Because in 
people with lower      socio- economic status, the literacy rate is poor 
which leads to poor knowledge of TB, risks of infection and delayed 
approach to health care facility. Poverty leads to poor nutrition and it 
suppress the immune system, and makes people vulnerable to 
tuberculosis62. 
Table 4 : Presenting complaints.  
The commonest complaint was constitutional symptoms 62%. It  
is due to elevation of  Lymphokines and cytokines such as IL12, TNF 
α,and TGF β65 which correlates with the study of  S.K Sharma 7 et al , 
where constitutional symptoms  was the major complaint in Extra 
pulmonary tuberculosis patients. The second commonest complaint in 
this study was breathlessness in extra pulmonary & Hemoptysis in  
pulmonary Tuberculosis  suspected patients. 
. Table 5 : ASSOCIATED DISEASES. 
Most common associated diseases among the tuberculosis 
suspected patients was Diabetes Mellitus(7%) followed by 
carcinomas(4%).This correlates withsalome64 et al, where Diabetes 
Mellitus was the most common associated disease, which is explained 
due to immunosuppression and its vulnerability to infection. 
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Table 6 : PAST  H/O TB AND TREATMENT H/O 
Among the 12 patients who had past H/o tuberculosis 10 patients 
completed the treatment and 2 patients defaulted, because of not 
knowing  the complications of tuberculosis.  
.Table 7 :  INVESTIGATIONS PROFILE FOR SYMPTOMATIC 
SMEAR NEGATIVE PULMONARY CASES. 
Out of 49 tuberculosis suspected patients 21(42%) had 
peripheral lymphocytosis, which is similar to 50. and 1(2%) was HIV 
positive 
Table 8 :  INVESTIGATIONPROFILE FOR SYMPTOMATIC  
EXTRA PULMONARY CASES 
  Among the 51 Extra pulmonary tuberculosis suspected 
patients,18 had increased lymphocytosis,16 had increased 
ADA(.50U/L) count in pleural fluid. This correlates with Sven O 
Friedrich et al and Verma et al in which there was  a  strong association 
of increased Adenosine de aminase levels.All 3 of the lymph node 
aspirates were positive for tuberculosis by Fine Needle Aspiration 
Cytology. 
Table 9 : Direct Microscopy by  Modified ZiehlNeelsen staining 
&Auramine O staining in Extra pulmonary specimens. 
Among the 51 Extra pulmonary specimens LED Fluorescent 
Microscopy by AuramineO stainingafter concentration 
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detectedmaximum  5(9.8%) samples, this correlates with Gerardo25 et 
al in which positivity of  LED microscopy in EPTB was 9.1%.In this 
study all the 5(9.8%) positive smears were pus/empyma, Psoas 
abscesses and lymph node aspirates which constitutes 5/12(40%) this is  
more or less similar toSiddiqui25et al in which lymphnode aspirates 
showed higher percentage of positivity(33%) 
In the present study  Ziehl-Neelsen staining detected 2(3.9%) 
samples before concentration and 3(5.9%) samples after concentration. 
This correlates with Siddiqui25 et al in which 5% were positive by ZN 
staining in EPTB. 
 In this study there was no difference in the detection rate of 
Ziehl-Neelsen& AO staining methods before concentration. The  
cumulative& valid percentage of detection is 3.9 for both, there is no 
statistical significance(0.735) with 95% Confidence Interval. 
According to Rohi11 et al, ZN  staining detected only 2% which exactly 
correlates with the present study. 
The sensitivity, specificity and positive predictive value  of 
Fluorescent Microscopy forExtra pulmonary specimensinthe present 
study was 29.4%,100%,80% respectively. 
 
124 
 
Table 10 : Culture Positivity By MGIT  in Smear Negative  
Pulmonary & Extra Pulmonary Specimens. 
In this  study MGIT(Mycobacterial Growth Indicator Tube )  detected  
17 among which 10/17(58.8%) where Mycobacterium tuberculosis 
complex and 7/17(41%) where  MOTT (Atypical mycobacteria).  
Among the 49 smear negative  pulmonary specimens, MGIT 
detected 8/49(16.3%)  in which M.tuberculosiscomplex was 3 and 
MOTT was 5,MGIT detected more atypical mycobacterias compared 
to Mycobacterium tuberculosis complex.This correlates with 
Mohamed35 et al in which the positivity in Smear negative specimens 
where 16%, and by Gaby 36 et al it was 14%. 
In this studyoverall  atypical mycobacterial detection was 7/17( 
41%) , but in smear negative pulmonary specimens, it was5/8(62%) 
which is less than  Gaby14et al where  MGIT recovered 39% of 
Atypical Mycobacterias. 
The recovery rate of MGIT for extra pulmonary specimens was 
18% in the present study, this correlates with the Arzu22 et al of 
17.6%.this is  higher than Hilleman8 et al in which recovery rate was 
7.8%. 
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Among  Extra pulmonary specimens, the positivity was higher 
for pus/empyema, Psoas abscesses and lymph node aspirates,out of 
9(18%) specimens it detected 5(55.6%). 
All the atypical mycobacterias were subcultered into Lowestein 
Jensen medium, among which 1 specimen produced pink  colored 
pigment in the presence of light and  so this was confimed as 
photochromogen, rest 6/7 samples showed growth in less than 7 days 
and this was confimed as rapid growers. 
  9% of cultures were contaminated with gram positive organisms, 
in this study  this is similar with Gaby14 6-8 %  &Mohamed et al 6.1%, 
Jacob37 et al 6.8 % ..To rule out bacterial and fungal contamination , 
positive MGIT tubes where subcultured into Blood Agar Plate, 
Macconkey Agar Plate and SDA(Sabouraud Dextrose Agar). 
 
Table 11 : ANTIMYCOBACTERIAL SENSITIVITY TESTING 
RESULTS BY MGIT 
Out of 17 MGIT positives, all 10/10( 100%) of MTBC strains  
were  sensitive to all four drugs Streptomycin(1.0µg/ml), Isoniazide 
(0.1µg/ml), Rifampicin(1.0µg/ml), Ethambutol(5.0µg/ml) which 
correlates with Palicova18et al the accuracy of MGIT was 
acceptable(>95%) 
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ATYPICAL   MYCOBACTERIA WITH PIGMENT 
 
SENSITIVE TO RIFAMPICIN , RESISTANT TO OTHERS 
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Among the 7 MOTT(Atypical mycobacteria) all  were 100 % 
resistant to three drugs streptomycin(1.0µg/ml) , Isoniazide(0.1µg/ml), 
Ethambutol(5.0µg/ml)., and only one sample was sensitive to 
Rifampicin(1.0µg/ml). This correlates with the study done by 
Gomathi16  et al , in which accuracy was >92%. 
Table 12 : SPECIMEN WISE GENE X PERT RESULTS  AND 
RIFAMPICIN SENSITIVITY: 
GENE X pert /RIF detected 26%  the sensitivity, specificity and 
positive predictive valve(PPV) of the MTB/RIF test was  60%,77%  
and  97%  this correlates with a study conducted by Rishi21 et al  in 
which sensitivity was 70%,  and the PPV was 100%.  
In this study  among  the 49 pulmonary  specimens ,  the  
detection rate was (10/26) 20%, and the sensitivity and specificity of 
the MTB/RIF test were50%, 80% respectively , which is less than  
82.3% and 100% respectively according to Rishi et al, which may be 
because of the inclusion of smear positive pulmonary specimens. 
                Gene X pert detected 16/51(31.3%) of extra pulmonary 
specimens,which correlates with a study conducted by Arzu21 et al 
where 32.1%.  The sensitivity & specificity of extra pulmonary 
specimens was 75% & 76%   this reports were higher than  Rishi et al 
in which, overall sensitivity of extra pulmonary specimens was 52.1%.  
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  Among the 9 pus samples it detected 8/9(89%).In lymph node  
aspirates out of 3 of specimens it detected all the 3/3(100%), this 
correlates with panayotis24 et al in which positivity in tissue samples 
was 70-80%. 
  Out of  3/100 (3%) of wound discharges , 1 sample was positive, 
rest of the 2  samples which came negative by Gene X pert/ RIF assay 
was further followed up , and  the FNAC report suggested of  having 
carcinomatous changes. 
In this study  the positivity was very less in pleural fluid among 
31/51(61%) detected only 4 /31(13%) , this is higher than the 
Hillemann et al  found 3% positive, and Causse9 et al 4/34(11.8%) 
positive , In a study by Sven23 et al  sensitivity is only 25 % but 
specificity is 100% for pleural fluid.In  pleural&Ascitic  fluid samples,  
the  positivity is  less, this could be due to the presence of aninhibitory 
substance which inhibited the amplification of the M. tuberculosis 
genome21.  
The results came invalid /error in  2% of pulmonary samples , 
98% of specimens gave interpretable results, one was insufficient 
sample and another came as error, this correlates with the  studies like 
Sven O 23et al and Panayatis24 et al  where uninterpretable results was  
1.8% and 2.4% respectively.Gene X pert detected all samples in less 
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than 2 hours. This test detects mycobacteria  very rapidly  < 2hrs 
compared to Gold standard culture methods like LJ in which mean 
time of detection is (31±9.4 days)35 and for MGIT  (9 ± 5 days ), 
Out of 26 % of positivity, Rifampicin resistance was detected in only 
one 1% of sputum sample, rest all were sensitive. 
13. TIME OF DETECTION OF POSITIVE SAMPLES BY MGIT. 
. The mean time of detection of MGIT was 9.6 days, in this 
study.However in different studies, time to detect Mycobacteria by 
MGIT falls in the range of  (11.6-14.4 days) according to Gaby 14 et al. 
 The mean time of detection for pulmonary specimens is 9.3 days.  For 
smear- negative specimens, it was 14.9 days according to Haung35 et 
al. 
The mean time of detection for MOTT(Atypical Mycobacteria) 
by MGIT  is just 5.8 days. This is statistical significance (p < 0.05), 
which is similar to Gaby 36 et al in which it is less than 7 days. 
The mean time of detection for Extra  pulmonary specimens is 
9.8 days. There is no statistical significance (p>0.05) between mean 
time of detection in smear negative  pulmonary and extra pulmonary 
specimens . 
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This correlates with  the study of Mohamed 35 et al and Pfyffer et 
al , where the mean time of detection was 9.9 days in pulmonary 
specimens.which correlates with the present study. Growth of 
M.tuberculosis complex in smear positive and smear negative 
specimens occurred in the MGIT after  5 days .  
Table 14 :  POSITIVITY BY FLUORESCENT MICROSCOPY, 
MGIT and Gene Xpert 
In total out of 100 specimens , Fluorescent Microscopy detected 
5, MGIT detected 17 and Gene Xpert detected 26%. This correlates 
with the study of Panayotis23  et al in which the positivity was 33.9%. 
compared to Microscopy & MGIT culture  Gene X pert detected the 
maximum this is because Xpert assay is seminested real time PCR , it 
can amplify even a single DNA copy, in contrast to f  MGIT Culture  
in which ,atleast 100 viable bacilli is essential. 
Table 15 &16 :RECOVERY RATE  OF MYCOBACTERIUM 
FROM CLINICAL SAMPLES  BY MGIT & GENE X PERT IN 
RELATION TO SMEARS. 
In smear negative pulmonary specimens out of  49/100( 49 % ) 
,MGIT detected  8/49( 16.3%) in  which 3(6.1%) were MTBC and 5 
(10.2%)  were MOTT atypical Mycobacteria.Gene X pert  detected 10 
/49 (20%) of smear negative specimens , which is higher than MGIT. 
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In smear positive Extra pulmonary specimens out of  5%  both 
MGIT & Gene X pert detected 5/5(100%) and more over  all of them  
belongs to Mycobacterium tuberculosis complex. This correlates with 
Badak35 et al MGIT positivity in smear positive specimens is 98%, & 
Pfyffer35 et al it was 88.5%. 
 In smear negative Extrapulmonary specimens  out of 46/51 
,MGIT detected 4(8.7%) among them 2(4.3%)  belongs to 
Mycobacterium tuberculosis complex ,&2(4.3%) belongs to MOTT 
atypical Mycobacteria. Gene X pert detected 11/46(24%) which in turn 
detectedextra 7/46 (15.2%)MTBC strains. 2 MTBC strains of MGIT 
were also detected by Gene X pert.MOTT was not detected. 
Overall in smear negative extra pulmonary specimens the 
detection rate is 11/46(%), this correlates with Doris Hilleman11et al 
and Arzu22 et al in but in  smear-positive extrapulmonary specimens 
positivity  was 100% (4/4)  and 37.7% (21/44) for smear-negative 
extrapulmonary specimens. 
Table 16 :RECOVERY RATE  OF MYCOBACTERIUM FROM 
CLINICAL SAMPLES  BY MGIT & GENE X PERT IN 
RELATION TO SMEARS. 
Among the 10 Mycobacterium tuberculosis complex strains, 
Fluorescent Microscopy detected  only 5/10(50%) , and Gene X pert 
detected 9/10 (90%). This correlates with Zeka21 et al in which 
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positivity of Gene Xpert  in smear negative and smear positive 
specimens in relation to MTBC culture strains was 57 to 70%, and 98- 
100 % respectively. The main disadvantage of Gene X pert is that,  it  
can detect only   MTBC, it is not designed to  detect   MOTT, because 
this does  not have the primer for MOTT . 
VEN DIAGRAM : 18 
In total the positivity of Gene X pert, excluding MOTT  is 
26/93(28%) ,in tuberculosis suspects , which is lower than the 
detection rate of  Sven 23 et al , this may be due to inclusion of higher 
number  ofpleural &ascitic fluid, which  constitutes 36/51(70 %)   in 
extra pulmonary specimens, as reported in different studies ,Sensitivity 
of Gene X pert is very low ranges from (5-25%)  for pleural &ascitic 
fluids ,positivity is on the lower side.  
A) Both MGIT + Gene X pert = 9/10. 
 MGIT & Gene X pert commonly detected 9/100 specimens , X pert 
missed one sample ,. 
B) MGIT alone positive , Gene X pert negative = 1. 
The reason could be the mutated  strain. 
C) MGIT negative ,Gene X pert alone positive = 17. 
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Gene X pert is an Nucleic Acid Amplification technique which 
is more superior than culture , because  a single DNA copy itself can 
get  amplified, But to get the  culture to be positive there should be 
atleast 100 CFU/ ml of specimen. 
D)Gene X pert negative, MGIT positive = 8 
As discussed , 7 was Atypical Mycobacteria & 1 was MTB 
complex, that could be a mutated strain . 
Table 18. There is no discrepancy in the Rifampicin sensitivity results 
for the 10 Mycobacterium tuberculosis complex strains. 
According to this study the positivity is higher in extra 
pulmonary specimens compared to  pulmonary specimens , this may be 
because of inclusion of smear negative specimens. Although 
Fluorescent microscopy detected only  5/100( 5%) of the specimens , 
there is 100 % agreement with the culture, all those five samples were 
positive by both MGIT culture & Gene X pert. 
Among the 10MGIT  Mycobacterium tuberculosis complex 
positive samples, LED  Fluorescent Microscopy after concentration 
detected 5 /10(50%). All the smear positive specimens were detected 
by both MGIT culture & Gene X pert. Although the sensitivity was 
low the specificity is 100 % . Since the positivity is only 9.8% in extra 
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pulmonary specimens , it will not be very much helpful in detecting  
Extra pulmonary Tuberculosis and also it did not detect even a single   
smear  negative pulmonary specimens even after concentrating the 
specimen. 
Gene X pert is a Catridge based semi nested multiplex PCR 
technique which detects Mycobacterium tuberculosis complexand 
Rifampicin Resistancerapidly in less than 2 hours from the clinical 
specimens directly with a higher positives. Furthermore this assay does 
not need any expertise training or sophisticated laboratory, and it is just 
a desktop machine which can be installed anywhere even in peripheral 
labs.The disadvantages are expensiveness  it is designed only for 
Mycobacterium tuberculosis complex detection, but  to identify 
atypical mycobacterias MGIT culture may  be used. 
The Micro MGIT system was found to be more efficient  in 
detecting mycobacteria in smear-negative& Extra pulmonary 
specimens compared to Fluorescent Microscopy 
Mycobacterium tuberculosis complex(MTBC)  detection was 
12% by Micro MGIT by Ruhi bund11 et al, and 8% by Hillemann11 et 
al, both of which are less than this study.. 
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SUMMARY 
This comparative  study was conducted to asses and compare the 
effectiveness of LED Fluorescent Microscopy, MGIT( mycobacterial 
Growth Indicator Tube )  and  Gene Xpert MTB/RIF assay, in smear 
negative pulmonary specimens and Extra pulmonary specimens from 
patients clinically and radiologically suspected of having 
Mycobacterium tuberculosis. 
In total of 49 smear negative pulmonary and 51 extra pulmonary 
patients, specimens such as  sputum, Bronchio alveolar Lavage  fluid, 
Pus, wound disharge, Lymph node aspirates, pleural and ascitic fluids 
were collected from patients. All the specimens were processed 
according to Standard  LaboratoryProcedures , to detect 
Mycobacterium tuberculosis . 
Out of 100 specimens , LED Fluorescent Microscopy detected 5, 
and there was 100 % agreement with MGIT and Gene Xpert 
MTB/RIF. 
MGIT culture detected 17/100(17%) in which 10/17(58%) were 
Mycobacterium tuberculosis complex  and  7/17(41%) were Atypical 
Mycobacterias. 
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 Gene Xpert MTB/RIF assay detected 26/100(26%) very rapidly 
in < 2 hrs.   
In smear negative pulmonary specimens MGIT detected 8(16.3) 
with mean time of detection of 9.3 days, where Gene Xpert detected 10  
Among the Extra pulmonary tuberculosis MGIT detected 9(18.5%) and 
Gene X pert detected 16(31%).                
In particular the positivity was higher among Pus, lymph node 
aspirates and wound discharges. So Gene Xpert may be exclusively 
considered for tissue  specimens . Even though the detection rate of X 
pert assay was less among pleural &ascitic fluids, it  detected more 
positives compared to MGIT & LED Fluorescent microscopy. 
Among the 10  MTBC culture positive strains Gene Xpert 
detected 9/10(90%).There was 90% agreement.  
In total GeneXpert assay detected 4 times more positivity 
compared toLED Fluorescent Microscopy and 3 times more than the 
culture, excluding atypical mycobacteria. There was no discrepancy in 
the drug susceptibility testing by MGIT and Gene X pert in 
RIFAMPICIN resistance detection.  
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The disadvantages of Gene Xpert is that it is designed to detect 
only Mycobacterium tuberculosis complex and not Atypical 
Mycobacteria . The instrument is also too expensive. 
According to this study, Atypical Mycobacteria  constitutes  
7/17(41%) among the positive cultures , so to identify  atypical 
mycobacteria MGIT culture may  be considered. LED Fluorescent 
microscopy & MGIT ( Gold standard culture) can be implementedin 
places where Gene X pert is not affordable.  
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CONCLUSION 
100 cases of smear negativepulmonary  tuberculosis  and  smear 
positive and smear negative extra pulmonary  tuberculosis suspected 
patients were included in  the study. Specimens were collected and 
processed for LED Fluorescent Microscopy, MGIT and  GeneXpert 
MTB/RIF assay. 
Overall ,ModifiedZiehl- Neelsen detected 3,Fluorescent 
Microscopy detected 5, MGIT detected 17 and Gene Xpert detected 
26.In smear negative pulmonary specimens MGIT detected 8 strains 
whereas Gene Xpert 10. Among the Extra pulmonary specimens ZN 
detected 3,Fluorescent Microscopy 5, MGIT detected  9, and Gene 
Xpert 16. 
  Compared to modified ZN staining ,Fluorescent Microscopy is 
superior which detected 5 .There was 100 % agreement between 
Fluorescent microscopy, in relation to MGIT culture and Gene Xpert. 
There was 90% agreement between MGIT & Gene X pert with respect 
to Mycobacterium tuberculosis complex identification. 
Among  the  MTBC strains detected by MGIT, all were sensitive 
to Streptomycin, Isoniazid ,Rifampicin, &Ethambutol, which  is also 
sensitive by Gene Xpert. There was no discrepancy in the sensitivity 
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results. Gene Xpert detected 1 MTBC Rifampicin Resistant  strain 
which was not picked up by MGIT.Among the 7 Atypical 
mycobacterias all were resistant to Streptomycin, Isoniazide, and 
Ethambutol ,except one strain which was sensitive to Rifampicin by 
MGIT.  
Although the cost of the equipment , cost per sample & 
maintenance charges are higher for Gene X pert  it detects MTBC 
DNA & Rifampicin Resistance very rapidly in < 2 hrs  directly from 
the clinical specimens  compared to all other methods.  
The results of this study indicated that the implementation of 
Gene Xpert MTB/RIF assay could dramatically improve the rapid 
diagnosis of tuberculosis  particularly in smear negative pulmonary  & 
extra pulmonary specimens such as pus, lymph node aspirates and 
wound discharges .Gene X pert negative specimens can be processed 
in MGIT  to recover Atypical Mycobacteria . 
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                                  Annexures 
APPENDIX 
1)Modified  Ziehl-Neelsen(cold method) 
Incrediants 
 a) Carbolfuchsin 
 Dissolve 4 g of basic fuchsin in 20 ml of 90-95% ethanol . 
 Then add 100 ml of 9% aqueous solution of phenol ( 9 g of phenol in 
100 ml of distilled water. 
b)Acid- Alcohol 
Add 3 ml of concentrated HCL slowly to 97 ml of 90-95% ethanol. 
c)Methylene Blue 
Dissolve 0.3 g of Methylene blue Chloride in 100 ml of Distilled 
water. 
 
2)AURAMINE FLUOROCHROME STAIN 
a) Phenolic auramine 
      Dissolve 0.1 g of auramine O in 10 ml of 90-95% etanol& 
Add 3 g of phenol in 87 ml of Distilled water 
b) Acid Alcohol 
      Add 0.5 ml of concentrated HCL to 100 ml of 79% alcohol. 
c) Potassium Permanganate 
Dissolve 0.5 gm of potassium permanganate in 100 ml of Distilled 
water 
 
 3 )Lowenstein - Jensens  medium 
 Ethanol                                                       70% 
 Malachite green solution                             2%,  
Malachite green dye 2 g 
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Sterile distilled water                                    100 ml 
 
 
 
PROCEDURE 
A) Using aseptic techniques, dissolve the dye in sterile distilled water. 
B)place the mixture in the incubator at 37 °C  for 1–2 hours or heat in a 
water-bath at 37°C. 
C) Store in dark bottles. 
D) This solution is not stable long-term: if precipitation occurs, discard 
and prepare a fresh solution.  
Salt solution  
Prepare the salt solution by dissolving the components in distilled 
water .Autoclave at 121 °C for 30 minutes in a screw-capped bottle. 
Hens' eggs  
Hens' eggs should be fresh (no more than 7 days old). The eggs should 
be medium-sized (for balanced proportions of egg white and egg yolk); 
about 23 eggs will be needed per litre of egg mass. 
procedure 
• Clean and disinfect the work area. 
• Clean  the eggs carefully with plain soap and water, soak them in 
70% ethanol for 15 minutes and let dry. 
• Crack each  egg  into a small sterile recipient in order to check its 
freshness. 
• Transfer the whole egg  into the conical flask with glass beads or 
magnetic stirrer or into the blender bowl. 
• Add sufficient eggs for the volume needed (as indicated in the table 
below). 
• Homogenize the egg mass.  
• Add the salt solution. 
• Add the malachite green. 
• Mix all components gently (to avoid bubbles) to homogeneity. 
• Filter through sterile cotton gauze.  
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• Dispense in 6–8 ml volumes into sterile McCartney bottles or 16 x 
125 mm screw-capped tubes. 
• Place the tubes on the racks so as to achieve appropriate slopes and 
inspissate at 80 °C for 45 minutes for three days. 
 
 
4)Blood agar  
Sterile sheep blood                                      5 ml  
Nutrient agar                                               100ml  
Autoclave the nutrient agar base at 121°C for 15 minutes.   
Cool to 45‐50 ºC and add  blood with sterile precautions   
and distribute in petri dishes. 
 
5) CHOCOLATE AGAR   
 Ingredients:  
  Nutrient agar base      30 gm.  
  Distilled water       1000 ml.  
  Sheep blood                100 ml.  
 Procedure:  
 1)Dissolve 30 g of Columbia agar base to 1 litre of distilled water in a 
flask.   Heat in a stem sterilizer to dissolve it completely.  
 2) Adjust the pH to 7.5 – 7.6.  
 3) Sterilize by autoclaving at 121° C for 15 minutes.  
4)Cool to 70° C in a water bath.  
5) 
 Aseptically add 100 ml of sheep blood to it and leave at 70° C for 30  
minutes.   
6)Mix the blood and agar by gentle agitation from time to time till bloo
d  becomes chocolates brown in colour. This takes about 10 minutes.  
 7) Pour as slopes or plates in sterile tubes or sterile Petri dishes.  
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 6)  SABOURAUD’S  DEXTROSE AGAR  Ingredients:  
   Dextrose            40.0 gm  
   Neopeptone           10.0 gm  
   Agar             15.0 gm  
   Distilled water           1000 ml  
 Procedure:  
 1) Mix the ingredients in distilled water by boiling. Adjust pH to 5.6.  
 2) Sterilize by autoclaving at 115° C for 15 min. 
  3) Allow to cool to 50° C.  
 4) 
Add Chloramphenicol 1 mg/ml of medium under aseptic precautions.  
 5) Pour 20 ml amounts in 90mm Petri dish or into 15 ml test tubes. 
  
6)Allow the test tubes to rest at an angle so that agar slopes (slants) are 
  obtained.  
7)After the medium solidifies, keep the Petri dish and cotton wool   
stopped dextrose agar slants in the refrigerator 
 
 
 
 
 
144 
 
Proper history will be collected from the patient with the following  
 PROFORMA: 
NAME                                                    : 
AGE                                                        : 
SEX                                                        : 
ADDRESS                                             : 
OP/IP NO                                              : 
MICRO ID NO                                     : 
H/o BCG VACCINATION                  : 
MANTOUX TEST RESULT               : 
               COMPLAINTS                                 : 
 
TREATMENT HISTRORY                : 
 
             GENERAL EXAMINATION           : 
 
             SYSTEMIC EXAMINATION         : 
 
             INVESTIGATIONS 
             BASIC BLOOD INVESTIGATIONS: 
 
             HIV STATUS                                     : 
             
             X RAY FINDINGS                            : 
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